Skip to main content
PLOS One logoLink to PLOS One
. 2024 Jan 2;19(1):e0296043. doi: 10.1371/journal.pone.0296043

Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: Systematic review of longitudinal studies

Anna Powell 1,2,*,#, Harry Sumnall 2,3,#, Jessica Smith 2,3,, Rebecca Kuiper 1,2,, Catharine Montgomery 1,2,#
Editor: Valerio Manippa4
PMCID: PMC10760842  PMID: 38166127

Abstract

Background

Alcohol use disorders (AUD) associate with structural and functional brain differences, including impairments in neuropsychological function; however, reviews (mostly cross-sectional) are inconsistent with regards to recovery of such functions following abstinence. Recovery is important, as these impairments associate with treatment outcomes and quality of life.

Objective(s)

To assess neuropsychological function recovery following abstinence in individuals with a clinical AUD diagnosis. The secondary objective was to assess predictors of neuropsychological recovery in AUD.

Methods

Following the preregistered protocol (PROSPERO: CRD42022308686), APA PsycInfo, EBSCO MEDLINE, CINAHL, and Web of Science Core Collection were searched between 1999–2022. Study reporting follows the Joanna Briggs Institute (JBI) Manual for Evidence Synthesis, study quality was assessed using the JBI Checklist for Cohort Studies. Eligible studies were those with a longitudinal design that assessed neuropsychological recovery following abstinence from alcohol in adults with a clinical diagnosis of AUD. Studies were excluded if participant group was defined by another or co-morbid condition/injury, or by relapse. Recovery was defined as function reaching ‘normal’ performance.

Results

Sixteen studies (AUD n = 783, controls n = 390) were selected for narrative synthesis. Most functions demonstrated recovery within 6–12 months, including sub-domains within attention, executive function, perception, and memory, though basic processing speed and working memory updating/tracking recovered earlier. Additionally, verbal fluency was not impaired at baseline (while verbal function was not assessed compared to normal levels), and concept formation and reasoning recovery was inconsistent.

Conclusions

These results provide evidence that recovery of most functions is possible. While overall robustness of results was good, methodological limitations included lack of control groups, additional methods to self-report to confirm abstinence, description/control for attrition, statistical control of confounds, and of long enough study durations to capture change.

Introduction

Alcohol use disorders (AUD) are associated with differences and impairments in brain structure and function, including in white and grey matter [13], event-related potentials [4], neurotransmitter and metabolic systems [3], and a range of neuropsychological functions, including executive functions, attention, reasoning/abstraction, visuospatial abilities, and verbal and visual short- and long-term memory [58]. It is important to understand whether these neuropsychological functional impairments can recover with abstinence, however the literature is inconsistent, with discrepancies between and within review-level work, both regarding the functions that recover, and the duration it takes [57]. Specifically, a review of prospective literature found consistent improvement of sustained attention, but inconsistencies for attention, executive function, or memory [7], while two methodologically similar reviews of primarily cross-sectional literature found conflicting results, with one concluding that all assessed domains recovered by a year of abstinence [6], and the other that there was a wide range of continued impairment at this stage [5].

Furthermore, there are methodological issues within this work, with findings derived mostly via cross-sectional research, which limits understanding of pre-existing differences and causality, and with tasks grouped under one function each [5, 6], rather than acknowledging that tasks and their different elements often span various domains and sub-domains [7]. The most suitable prior review is Schulte, Cousijn [7], due to its only including longitudinal studies, and grouping tasks under multiple domains, but even this found inconsistent results, so a more up-to date review is needed. As neuropsychological impairments in AUD can impact treatment outcomes [9], and reduce quality of life [10], research clarifying their recovery is important to inform support throughout treatment and recovery. For the sake of brevity, a more in-depth justification of this review is described elsewhere, in the published protocol [11].

Objective(s)

The primary objective of this paper was to systematically review the literature to assess neuropsychological function recovery following abstinence in individuals with a clinical AUD diagnosis. The secondary objective was to assess predictors of neuropsychological recovery in AUD.

Method

The review protocol (which was consistently adhered to) was both registered on PROSPERO (CRD42022308686), and peer-reviewed and published prior to commencement [11]; please see these for a detailed description of review methods, including a template data extraction form. Briefly, four sources (APA PsycINFO, EBSCO MEDLINE, CINAHL, and Web of Science Core Collection), were searched for results from the year 1999 onwards (see S3 Table for search strategies), with hand searching and forward searching also undertaken (see Fig 1 for PRISMA flowchart). Searches were initially run on 10/03/2022 and were re-ran on the 17/03/2023 prior to finalising the synthesis. Longitudinal studies of adults aged 18–64 with a diagnosis of AUD (either mild/moderate/severe via DSM-5, dependence or abuse via DSM-IV, or dependence or harmful use via ICD-10/11), which assessed change in neuropsychological function upon abstinence were included. Change must have been measured using either validated self-report/tasks, or clinical diagnoses/progression of neuropsychological impairment. Baseline could occur before or during active AUD, or in early recovery (a month or less since last used alcohol), and first follow-up could occur from at least two weeks of abstinence onward. A comparator was required, in the form of adults aged 18–64 without AUD, adults with a different severity of AUD, or abstinence duration assessed using regression techniques. Studies were excluded if the population was defined by use of other substances, or another/co-morbid condition (including alcohol-related brain injury, major psychiatric condition, head trauma, or relapse). If participants were reported as consuming other substances, alcohol must have been the primary substance (no comorbid substance use disorders), with the exception of individuals with tobacco use disorder (though again, studies were not included if they specifically recruited individuals with AUD who use tobacco).

Fig 1. PRISMA chart of study process.

Fig 1

Screening was undertaken by three assessors, one who screened all data (AP), and two others who each screened half (JS and RK). Inter-reviewer consistency was determined prior to screening and determined to be good (AP and RK [κ = .747, p < .001]; AP and JS [κ = .641, p < .001]), after which a discussion was held to benchmark criteria. See S4 Table for details of studies excluded at the full-text stage. Upon completion of screening, data extraction was undertaken by AP to obtain authors; year; setting; location; participant demographic characteristics; exact diagnosis; recruitment/follow-up procedures; change in neuropsychological function; data relating to secondary aims (characteristics reported as predictors of neuropsychological recovery). Quality assessment using JBI Checklist for Cohort Studies was independently conducted by RK and KS for 10% of articles, while AP assessed all. A narrative synthesis was conducted due to heterogeneity, which included tabular presentation, a preliminary synthesis, explored relationships in the data, and examined synthesis robustness [12, 13]. The seminal book “Neuropsychological Assessment” by Lezak, Howieson [14] was used to guide synthesis grouping, which included grouping tasks across multiple domains and sub-domains where appropriate (see Table 2 for more information on how tasks were grouped).

Table 2. Grouping of neuropsychological functions and tasks.

Domain Sub-domain Abbreviation Task (& if pertinent, specific task outcome)
Attention Focused Attention FA CI, ST, D2, CPT, RVP
Divided Attention DA TMT-B, G/L
Processing Speed PS Alt, ST (congruent RT), TMT-A, MST, D2, CRT, DD, DS, RVP (RT correct, RVP-B), CI (RT), AVF
Attentional Capacity AC DF, SSp, DSp, AS
Executive Functions Planning P SOC
Decision Making DM IGT, CGT
Working Memory Updating/ Tracking WMU/T DB, B-P, L-N, N-b, RVP, AS
Response Inhibition RI ST (incongruent), commission errors on AGN, RVP, CI & CRT
Verbal Fluency VF CWA, ANT, AVF
Flexibility F WCST (perseverative errors), MCST (perseverative errors), IED (extra dimensional errors), Flx, TMT-B, TMT B-A, HCT, AVF
Concept Formation & Reasoning Visual Concept Formation VCF HCT, MR, RPM
Sort and Shift S WCST (perseverative errors, categories achieved), MCST (perseverative errors, categories achieved), IED (extra dimensional errors, stages completed)
Learning & Memory Short-term memory STM MF
Verbal short-term memory Ver STM VPA (immediate recall), FCSRT (immediate free recall), RAVL (immediate recall), CVL (total recall)
Verbal long-term memory Ver LTM VPA (delayed recall), FCSRT (delayed free recall), RAVL (delayed recall), CVL (delayed recall), VLT, DFR
Visual short-term memory Vis STM B-P, ROCF (immediate recall), BVM (total recall), BVRT, DVD
Visual long-term memory Vis LTM CMT, NVLT, ROCF (delayed recall), BVM (delayed recall), PRM
Perception Figure & Design FD B-G, CoF, ROCF (immediate recall)
Emotional Facial Expression EFE EFERp
Visual Interference VI HFT
Verbal Functions Vocabulary V Vc
Motor Performance Fine Motor Function FM B-G, MST, CoF, ROCF (immediate recall)

Tasks: AGN, Alcohol Go/No-Go Task; Alt, Alertness subtest of Test of Attentional Performance; ANT, Animal Names Test; AS, Alphabetical Span subtest of the Brief Examination of Alcohol-Related Neuropsychological Impairment; AVF, Alternating Verbal Fluency subtest of the Brief Examination of Alcohol-Related Neuropsychological Impairment; B-G, Bender-Gestalt Test; B-P, Brown-Peterson Technique; BVM, Brief Visuospatial Memory Test revised; BVRT, Benton Visual Retention Test; CGT, Cambridge Gambling Task; CI, Crossmodal Integration subtest of Test of Attentional Performance; CMT, City Map Test; CoF, Copy of Figures; CWA, Controlled Word Association (F-A-S); CPT, Continuous Performance Test– 2nd Edition; CRT, Choice Reaction Time subtest of CANTAB; CVL, California Verbal Learning Test revised; D2, D2 Cancellation Test; DB, Digit Span backward; DF, Digit Span forward; DFR, Delayed Free Recall subtest of the of the Brief Examination of Alcohol-Related Neuropsychological Impairment; DS, Digit Symbol subtest of Wechsler Adult Intelligence Scale– 3rd Edition; DSp, Digit Span unspecified (likely composite score of Forwards and Backwards); DVD, Delayed Vernier Discrimination; EFERp, Emotional Facial Expression Recognition paradigm; FCSRT, Free and Cued Selective Reminding Test; Flx, Flexibility subtest of Test of Attentional Performance; FSIQ, Full-Scale-IQ-2 of Wechsler Abbreviated Scale of Intelligence– 2nd Edition; G/L, Global/Local paradigm; HCT, Halstead Category Test; HFT, Hidden Figure subtest of the Brief Examination of Alcohol-Related Neuropsychological Impairment; IED, Intra-Extra Dimensional Set Shift subtest of CANTAB; IGT, Iowa Gambling Task; L-N, Letter-Number Sequencing; MCST, Modified Card Sorting Test; MR, Matrix Reasoning subtest of Wechsler Abbreviated Scale of Intelligence– 2nd Edition; MST, Motor Screening Test subtest of CANTAB; N-b, N-back (2-back); NVLT, Nonverbal Learning Test (German version of Kimura Recurring Figures Test); PRM, Pattern Recognition Memory subtest of CANTAB; RAVL, Rey Auditory Verbal Learning Test; ROCF, Rey-Osterrieth Complex Figure Test; RPM, Raven’s Progressive Matrices; RVP, Rapid Visual Information Processing subtest of CANTAB; SOC, Stockings of Cambridge subtest of CANTAB; SS, Symbol Search subtest of Wechsler Adult Intelligence Scale– 3rd Edition; SSp, Spatial Span composite Forwards and Backwards; ST, Stroop Colour and Word Test; TMT B-A, Trail Making Task part B minus part A; TMT-B, Trail Making Task part A; TMT-B, Trail Making Task part B; Vc, Vocabulary subtest of Wechsler Abbreviated Scale of Intelligence– 2nd Edition; VLT, Verbal Learning Test (German version of Recurring Words Test); VPA, Verbal Paired Associates subtest of Wechsler Memory Scale– 3rd Edition; WCST, Wisconsin Card Sorting Test.

Results

Eighteen studies longitudinally measured neuropsychological recovery from AUD, with follow-ups ranging from 14–18 days of abstinence to 24 months. Three studies were described as using mostly the same cohort [1517], so the study with the longest follow-up duration at eight months [15] was selected to be the primary source for this cohort. The details of the sixteen studies included in the synthesis can be found in Table 1. Of these, eleven studies compared neuropsychological function to controls (though four of these only tested controls once, and one of these only compared AUD baseline performance to controls, while another only compared AUD follow-up to controls), while two compared to test-provided normative data. The remaining three studies did not compare AUD function to ‘normal’ performance but did assess the impact of abstinence duration using regression analyses. As a result of these methodologies, it is not possible to exclude the confounding impact of practice effects on neuropsychological improvement. The main finding of the review is that sub-domains within attention, executive function, perception, and memory, demonstrate recovery to ‘normal’ performance levels, generally between 6–12 months. A more in-depth synthesis is now provided.

Table 1. Study characteristics, tasks measured, and outcomes, grouped by study quality (good, moderate, poor).

Author, Year Country, Economic status at time Setting Diagnostic tool % Male Average age (years) Timepoints
(d = day, w = week, m = month)
Sample size at each time Comparator Tasks Function at T0,
impaired vs controls or normative data/not impaired or not compared
Function at follow-up, improvement/ no change, or not reached normal performance if compared/ worsened. Significance level p ≤ .05.
Good study quality
Alhassoon et al., 2012 USA
High
Inpatient DSM-IV, AD 100 51.4 ± 6.0 T0 = 2w
T1 = 12m
T0 = 19
T1 = 15
15 controls (51.8 ± 7.4 years, 100% Male), assessed twice in same interval. Matched age/education. TMT-B
DB
HCT
DA, F
WMU/T
F, VCF
DA, F
WMU/T
F, VCF
Angerville et al., 2023 France
High
Inpatient DSM-IV, AD 75 45.5 ± 6.8 T0 = 8 ± 2d
T1 = 18 ± 2d
T0 = 32
T1 = 32
32 controls, and normative data, but no tests of statistical significance to either at T0. Regression methods assessed impact of abstinence duration. DFR
AS
AVF
HFT
Ver LTM
AC, WMU/T
PS, VF, F
VI
Ver LTM
AC, WMU/T
PS, VF, F
VI
Bartels et al., 2007 Germany
High
Outpatient DSM-IV, AD 71.9 44.7 ± 6.2 T0 = 2-3w
T1 = 3m
T2 = 6m
T3 = 12m
T4 = 24m
T0 = 50
T4 = 32
Normative data. Three groups; hippocampal dysfunction (HC group) implied by related tasks, no HC dysfunction, additional brain damage, indicated by clinical diagnostics). CI
Alt
VLT
NVLT
CMT
PS, RI, FA
PS
Ver LTM (HC group)
Vis STM (HC group)
Vis LTM (HC group)
PS, RI, FA in HC group by T4
PS
Ver LTM by T3 & T4 (HC group)
Vis STM by T3 & T4 (HC group)
Vis LTM by T4 (HC group)
Czapla et al., 2016 Germany
High
Inpatient DSM-IV, AD 81 48.05 ± 9.26 T0 = 2-4w
T1 = 6m
T0 = 94
T1 = 44 (32 of whom relapsed)
71 healthy controls (46.00 ± 12.02 years, 76% Male), assessed once. Controls only compared at baseline. Regression methods assessed impact of abstinence duration. RVP
CRT
CGT
AGN
IED
FA, PS, RI, WMU/T
PS, RI
DM
RI
F, S
FA, PS, RI, WMU/T
PS, RI
DM***
RI***
F, S
Durazzo et al., 2014 USA
High
2+ Outpatient DSM-IV, AD 84 ns
85 fs
96 as
ns = 50 ± 10
fs = 55 ± 13
as = 50 ± 9
T0 = 1w
T1 = 1m
T2 = 8m
T0 = 93
T1 = 133
(58 added)
38 never smoking controls from local community (47 ± 9 years, 89% Male), assessed twice in similar interval. Regression methods assessed impact of abstinence duration. Within AUD, never smokers = ns, former smokers = fs, active smokers = as. SS
DS
DSp
CVL
BVM
PS (fs & as)
PS
AC
Ver STM (as) Ver LTM
Vis STM, Vis LTM (fs & as)
PS by T1 & T2
PS by T1 & T2 (fs & ns, not as)
AC by T1 (ns & as) & T2
Ver STM (fs & as), Ver LTM (as) by T1, Ver STM, Ver LTM by T2
Vis STM, Vis LTM by T2 (fs, not as)
Foisy et al., 2007 Belgium
High
Residential post-detox centre DSM-IV, AD 57.1 42.44 ± 8.05 T0 = 3-4w
T1 = 3m
T0 = 49
T1 = 22
22 controls (44.86 ± 9.31 years, 54.5% Males), tested twice over same interval. Matched age (± 5 years)/ gender/ education. Regression methods assessed abstinence duration impact EFERp EFE EFE
Ioime et al., 2018 Italy
High
2 Outpatient DSM-IV-TR, AD 75 46.63 ± 8.5 T0 = 12-17d
T1 = 6m
T2 = 12m
T0 = 41
T1 = 37
T2 = 27
40 controls (46.60 ± 6.2 years, 70% Males), tested once. Regression methods assessed impact of abstinence duration. ST
TMT-B
TMT B-A
MCST
RPM
RAVL
ROCF
CoF
FA, RI
DA, F
F
F, S
VCF
Ver STM, Ver LTM
FM, FD, Vis STM, Vis LTM
FD, FD
FA, RI by T1 & T2
DA, F by T1 & T2
F by T1 & T2
F, S by T1 & T2
VCF
Ver STM, Ver LTM by T1, Ver LTM by T2
Fm, FD, Vis STM, Vis LTM by T2
FM, FD by T1 & T2
Loeber et al., 2010 Germany
High
Inpatient DSM-IV, AD 60.4 HD = 47.4 ± 8.4
LD = 44.9 ± 7.7
T0 = ≥ 5d after end of medication
T1 = 3m
T2 = 6m
T0 = 48
T1 = 35
T2 = 28
36 controls (44.4 ± 9.1 years, 56.3% Male), assessed twice in three months. Matched age/ gender/ premorbid intelligence. Grouped by previous detoxes; 2+ detoxes, High-detox = HD, others Low-detox = LD. IGT
TMT-B + WCST
RAVL + BVRT
M
DA, F
Ver STM, Vis STM
M
DA, F by T1, DA, F by T2***
Ver STM, Vis STM
Petit et al., 2017 Belgium
High
2 Inpatient DSM-IV, AD 73.2 49.54 ± 11.58 T0 = 1d
T1 = 18d
T0 = 41*
T1 = 41*
41 healthy controls (43.80 ± 11.34 years, 41.5% Male), assessed twice in same interval. Matched age/gender. ST
DF
B-P
FA, PS, RI
AC
WMU/T, Vis STM (10 & 20 sec delays, not 0 or 5 sec)
FA, PS, RI
AC
WMU/T, Vis STM (10 & 20 sec delays)
Pitel et al., 2009 France
High
Inpatient DSM-IV, AD ** 47.31 ± 7.42 T0 = 9.58 ± 4.42d
T1 = 6 m
T0 = 54
T1 = 21 (9 of whom relapsed)
54 controls (47.27 ± 6.80 years, ** % Male), tested once. Matched age /education. ST
N-b
Flx
FCSRT
FA
WMU/T, U
F
Ver STM, Ver LTM
FA
WMU/T
F
Ver STM, Ver LTM
Wegner et al., 2001 Germany
High
Inpatient ICD-10 & DSM-IV, AD/ misuse 84.2 44.6 ± 2.14 (SEM) T0 = 0-4d
T1 = 14-18d
T0 = 19
T1 = 19
19 controls (42.2 ± 1.75 years (SEM), 47.4% Males), tested twice in 3-week span. Matched age/ education. Regression methods assessed impact of abstinence duration. G/L
DVD
DA
Vis STM
DA
Vis STM
Moderate study quality
Cordovil De Sousa Uva et al., 2010 Belgium
High
Residential DSM-IV, AD 48.5 48.40 ± 8.2 T0 = 1-2d
T1 = 14-18d
T0 = 35*
T1 = 35*
22 controls (44.36 ± 9.64 years, 63.6% Male), assessed twice. Matched age/ gender/ education. IGT performed on split sample, each half did IGT at T0 or T1. ST
D2
TMT-A
TMT-B
TMT B-A
IGT
FA, PS, RI
FA, PS
PS
DA, F
F
DM
FA, PS, RI
FA, PS
PS
DA, F
F
DM
McCutcheon et al., 2016 USA
High
3 likely Outpatient DSM-5,
AUD (27 severe, 1 mild)
0 42.3 ± 9.5 T0 = 27.7 ± 10.2d
T1 = 4 m
T0 = 28
T1 = 18
No comparison group. Regression methods assessed impact of abstinence duration. CPT FA FA
Yeh et al., 2007 USA
High
2+ Outpatient DSM-IV, AD/ abuse 93.3 ns = 51.5 ± 9.6
s = 47.2 ± 9.8
T0 = 1w
T1 = 1m
T2 = 7m
T0 = 50
T1 = 46
T2 = 17
Controls not in statistical model of function recovery. Regression methods assessed impact of abstinence duration. Within AUD, non-smokers = ns, smokers = s. BVM Vis STM, Vis LTM Vis STM by T1, Vis LTM by T1 (s) & by T2 (ns)
Poor study quality
Kaur et al., 2020 India
Lower-middle
Outpatient and Inpatient ICD-10, AD 100 41.83 ± 9.16 T0 = 0d
T1 = 1m
T2 = 3m
T0 = 60
T1 = **
No comparison group. Regression methods assessed impact of abstinence duration. SSp
L-N
CWA
ANT
WCST
B-G
AC
WMU/T
VF (phonemic)
VF (category)
F, S
FD, FM
AC by T1 & T2
WMU/T by T1 & T2
VF by T1 & T2
VF by T1 & T2
F, S by T1 & T2
FD, FM by T2
Manning et al., 2008 UK
High
Inpatient ICD-10, AD 63 44.0 ± 7.6 T0 = 3.8 ± 0.9d
T1 = 12m
T0 = 30
T1 = 30
Scores scaled according to age-matched test-provided normative data. Regression methods assessed impact of abstinence duration. MST
SOC
L-N
CWA
ANT
IED
MR
VPA
PRM
Vc
PS, FM
P
WMU/T
VF (phonemic)
VF (category)
F, S
VCF
Ver STM, Ver LTM
Vis LTM
V
PS, FM
P
WMU/T
VF
VF
F, S
VCF
Ver STM, Ver LTM
Vis LTM
V

*Stated that relapsers were excluded from study, but these were not described in numbers or characteristics

** data unknown

*** impaired vs controls at baseline, but not compared to controls at indicated time

Impaired function in this review is understood to be that which is significantly worse than control or normative level, while recovery is when function reaches this. Therefore, studies that did not statistically compare to controls or normative performance at baseline and follow-ups have been used to provide an indication of improvement rather than full recovery. Classification of functional domains and sub-domains are displayed in Table 2. A preliminary synthesis was conducted, which involved creating a recovery matrix of all function domains over time (see Fig 2). This informed the narrative synthesis reported below.

Fig 2. Recovery matrix of function over time.

Fig 2

1.1 Attention

Fourteen studies assessed attention, with follow-ups ranging from 14–18 days of abstinence to 24 months. Of those comparing to ‘normal’ performance, complete attentional recovery was indicated by twelve months of abstinence at the latest, though there were indications of recovery earlier than this for the sub-domains.

1.1.1 Processing speed

Six studies assessed processing speed, with follow-ups ranging from 14–18 days of abstinence to 24 months. Initial impairment was inconsistent, but this may be due to some studies conducting baseline testing too late to capture this. Basic processing speed recovers by one month, but not when other task and goal related elements are involved, such as accuracy on more complex tasks. There is also some indication that verbal processing speed improves faster than visual.

Half of the studies which did not find an initial impairment had generally not conducted baseline testing until at least two weeks of abstinence had already passed [18, 19], except for Petit, Luminet [20], Manning, Wanigaratne [21]. Of those that did find an initial impairment, two conducted baseline assessment within a week of abstinence [15, 22], whilst the third was later at 18 days of abstinence but used a more complex attentional assessment (Rapid Visual Information Processing task, RVP) and recorded reaction time (RT) for correct responses only [19]. Recovery was indicated to occur by a month of abstinence onwards for two basic processing speed tasks [15], Digit Symbol Substitution (DS) and Symbol Search (SS), but processing speed of correct responses on RVP was still impaired by six months [19]. A task with somewhat ‘moderate’ executive complexity requiring flexibility (Alternating Verbal Fluency, AVF) did display improvement by 18 ± 2 days [23]. Interestingly, this is the only study to have used a verbal task of processing speed, perhaps indicating that this improves faster than visual processing speed. Only Durazzo, Pennington [15] specifically assessed predictors of processing speed recovery. Independently, age and premorbid verbal intelligence predicted change on both tasks in Durazzo, Pennington [15] across the whole sample. Additionally, differential recovery was indicated as a result of smoking status, with active smokers demonstrating the poorest outcomes in both DS and SS (indeed, not recovering to control performance on DS). Furthermore, as a supplementary finding in the same cohort from a secondary source, processing speed recovery in non-smokers was associated with increasing volumes in lobar grey and white matter regions and subcortical regions during 7.5 months of abstinence, though volume increase was similar between smokers and non-smokers, so this is unlikely to explain functional recovery differences between the two groups [16]. Angerville, Ritz [23] did assess predictors of Brief Evaluation of Alcohol-Related Neuropsychological Impairment ‘cognitive score’, which encompasses processing speed, attentional capacity, working memory updating/tracking, verbal fluency, flexibility, verbal long-term memory, and visual interference. Alcohol Use Disorders Identification Test (AUDIT) scores (which measures alcohol consumption, dependence symptoms, and negative consequences) and age of onset of first alcohol consumption were both significant predictors, with lower age of onset and higher AUDIT score associated with poorer recovery. However due to the composite nature of the predicted outcome, more specific conclusions relating to individual functions cannot be drawn.

1.1.2 Attentional capacity

Attentional capacity was assessed by four studies only, and initial impairment and recovery was inconsistent. Follow-ups ranged from 18 days of abstinence to 8 months. It is likely that attentional capacity is not impaired in AUD, and that impairments and improvements in the other studies are more likely working memory performance related.

Petit, Luminet [20] used Digits Forward, a more specific test of capacity [24], finding no impairment or change up to 18 days of abstinence. In contrast, Durazzo, Pennington [15] appeared to use a composite of Digits Forward and Backward, finding impairment, and Kaur, Sidana [25] used a composite of Forwards and Backwards Spatial Span. Composite span measures may be confounded by impairments of working memory [14]), and both indicated improvement, but it is hard to separate this from possible working memory changes. Similarly, Angerville, Ritz [23] used the Alphabetical Span subtest, which involves working memory manipulation, and also found indications of initial impairment (though this was not confirmed using tests of significance), and improvement by 18 days. Furthermore, differences may also be confounded by the modality of span used, as visuospatial and verbal tasks may involve modality-specific processes [26].

Again, age and premorbid intelligence were independent predictors of recovery across AUD [15], and although only never smokers were impaired versus controls at one week of abstinence, only former smokers were at one month. This may indicate a co-occurring impact of smoking and AUD on attentional capacity (or indeed, working memory) in some patients. As mentioned previously, Angerville, Ritz [23] who used a composite cognitive score which included attentional capacity as one of the contributing functions, found that lower age of onset of first alcohol use and higher AUDIT score associated with poorer recovery.

1.1.3 Focused attention

Seven studies assessed focused attention, with follow-ups ranging from 14–18 days of abstinence to 24 months. This was generally initially impaired, which was consistent in early abstinence. Recovery was inconsistent but indicated to occur by 6–12 months in some cases, with discrepancies across baseline and recovery possibly driven by task and methodology differences.

Of the six studies that compared function to normal performance, two found no initial impairment [18, 27], whilst four did [19, 20, 22, 28], one of which [22], used two measures. By 14–18 days of abstinence there was continued impairment [20, 22], while in McCutcheon, Luke [29], who did not recruit controls, performance improved by three months. Performance at six months was inconsistent, with Ioime, Guglielmo [28] finding recovery to control levels on the Stroop, but Czapla, Simon [19] still finding impairment on the RVP. Recovery in Ioime, Guglielmo [28] was maintained at 12 months.

While Pitel, Rivier [27] used the Stroop test, the main outcome was the number of colours named in the interference condition, but other Stroop studies used a combination of incongruent trial RT, and/or isolated incongruent performance from neutral trial performance in some way. These measures may have been more able to comprehensively assess focused attention, as they would be more sensitive to problems with efficiency and executive inhibitory control deficits [30], which are required for focused attention [31]. Indeed, other studies finding impairment in focused attention may have done so due to its reliance on efficiency and inhibitory control, as Continuous Performance Test score in McCutcheon, Luke [29] is a combination of commission errors (response inhibition), and RT correct, while D2 Cancellation Test (used in Cordovil De Sousa Uva, Luminet [22]) assesses speed concurrently with focus, as it is time limited [32]. Furthermore, in Czapla, Simon [19], RVP commission errors (response inhibition) and RT correct (processing speed) were impaired, indicating that there were issues with efficiency and response inhibition, which could possibly have contributed to poor performance on the task overall. This is not supported however by Bartels, Kunert [18], who found no processing speed or inhibitory deficits or change on the task used, but with the latest attention baseline assessment at 2–3 weeks, this finding is less reliable.

When considering the conflicting findings at six months, the RVP task used by Czapla, Simon [19] may arguably involve another layer of functional ability compared to the Stroop (alongside inhibition and efficiency), as it requires a participant to detect target digit sequences by witnessing one digit at a time, so the individual must remember the previous one or two digits (dependent on trial difficulty) to state whether the overall sequence matches that of the target sequence. This involves working memory updating/tracking, which is not required by the Stroop task, perhaps explaining why performance on this task was still impaired.

Regarding predictability, McCutcheon, Luke [29] found that in their women only sample, increases in network drinking scores (drinking behaviour of people important to the individual) between 1–4 months of abstinence, was associated with worsening focused attention, whilst the opposite was true for those whose network drinking decreased.

1.1.4 Divided attention

Five studies assessed divided attention, which was generally impaired at baseline, and demonstrated recovery by around six months. Follow-ups ranged from 14–18 days of abstinence to 12 months. Of the five studies, four found initial impairment at baseline [22, 28, 33, 34], while one did not [35]. This impairment improved by six months [28, 33], to the same level as controls [28], which was maintained at 12 months [28]. Improvement to control level was observed very early in Wegner, Günthner [36], by 14–18 days of abstinence, however compared to the other measures, they used a much simpler divided attention task (a Global/Local paradigm), with current findings suggesting this may not be able to capture continued impairment in AUD.

Alhassoon, Sorg [35], was the exception, finding no impairment vs controls on TMT-B, and no change by 12 months of abstinence, which could be related to the late baseline assessment in this study. Furthermore, the sample in Alhassoon, Sorg [35] were all male, and previous research has demonstrated gender differences on the TMT tasks [37]. Although the exact nature of this relationship is not consistent throughout the literature, at least one study has found that men demonstrate better performance on TMT-B [38].

Predictability was not generally assessed. However, Loeber, Duka [33] found that individuals with two or more previous detoxes performed poorer than those with fewer previous treatments by six months of abstinence on a composite EF/attention score, indicating that repeated cycles of withdrawal and relapse have a damaging influence regarding recovery of divided attention and cognitive flexibility.

1.2 Executive functions

Eleven studies assessed aspects of executive function, one of which assessed planning, three decision-making, seven working memory updating/tracking, six response inhibition, three verbal fluency, and nine cognitive flexibility. Despite these abilities being related, the studies demonstrated differential recovery of sub domains. Follow-ups ranged from 14–18 days of abstinence to 24 months.

1.2.1 Planning

Planning, assessed using the Stockings of Cambridge task (total score and problem-solving speed), was initially impaired and continued to be so at 12 months of abstinence [21]. Further research is needed to confirm this.

1.2.2 Decision making

Decision making was generally impaired at baseline and demonstrated some improvement by six months of abstinence. Follow-ups ranged from 14–18 days of abstinence to 6 months. Interestingly, while Cordovil De Sousa Uva, Luminet [22] and Czapla, Simon [19] found initial impairment, which persisted at 14–18 days of abstinence, Loeber, Duka [33] did not, and found no change by three or six months. Czapla, Simon [19] did not compare to controls beyond baseline but did find some improvement by six months, indicating that when decision making is impaired, improvement can take up to six months.

It is unclear why Loeber, Duka [33] did not find impairment at baseline or change in performance, given that the initial baseline assessments occurred at an abstinence duration comparable to the other two. Loeber, Duka [33] controlled for premorbid intelligence (Vocabulary Test; Schmidt and Metzler [39]) in their analysis, but both Cordovil De Sousa Uva, Luminet [22] and Czapla, Simon [19] reported that controls and AUD participants did not differ regarding educational level, so this is less likely to be the cause of discrepancy, and all three either matched controls on age and gender, or reported no differences in these between the groups. It is possible that another confounding factor that was not assessed or controlled for contributed to the inconsistency.

1.2.3 Working memory updating/tracking

Working memory updating/tracking was typically impaired at baseline and demonstrated recovery from as early as 18 days into abstinence, which was generally maintained up to a year of abstinence. Follow-ups ranged from 14–18 days of abstinence to 12 months. The majority of studies found initial impairment (except Manning, Wanigaratne [21]), which typically demonstrated full recovery across studies, including at 18 days [20], six months [27], and 12 months [35], with continued improvement not compared to controls at one and three months [25]. Similarly, Angerville, Ritz [23] also found improvement to control performance level by 18 ± 2 days, though initial deficit was not confirmed using tests of significance. However, Czapla, Simon [19] found continued impairment at six months.

Despite Manning, Wanigaratne [21] not finding initial impairment compared to normative data, their participants did demonstrate improvement by 12 months, though it is unclear why the initial discrepancy occurred. Regarding predictors, as previously described, Angerville, Ritz [23] found that lower age of onset of first alcohol use and higher AUDIT score predicted poorer recovery of a composite cognitive score which included working memory updating/tracking as one of the contributing functions.

1.2.4 Response inhibition

Response inhibition was generally impaired at baseline, and in the majority, demonstrated improvement and in some cases, full recovery between 6–12 months. Follow-ups ranged from 14–18 days of abstinence to 24 months. Five of the studies found initial impairment (except for Crossmodal Integration (CI) commission errors in Bartels, Kunert [18], words recalled in incongruent Stroop in Pitel, Rivier [27], and choice RT in Czapla, Simon [19]). Cordovil De Sousa Uva, Luminet [22] and Petit, Luminet [20] both found that inhibitory control on the Stroop was still impaired around 18 days into abstinence. This recovered to control levels in Ioime, Guglielmo [28] by six months, which was maintained at 12 months. However, while Czapla, Simon [19] found, like Ioime, Guglielmo [28], that response inhibition on an alcohol Go/No-Go (AGN) task improved at six months, commission errors on the CANTAB RVP were still impaired.

As discussed before, as the RVP involves response inhibition and working memory updating/tracking, both of which alone typically demonstrated recovery from six months onwards, this may indicate that when a participant with AUD must perform multiple executive processes at once, performance still suffers compared to controls at this stage. Future research could examine the effect of combined executive processes on performance, as this may be closer to demonstrating real-world executive deficits. Alternatively, this may indicate a difference in the cohort measured by Czapla, Simon [19], but as there was improvement on the AGN this seems less likely (no initial inhibitory deficit on choice RT may be explained by task simplicity [40] relative to the other two examined in this study). Furthermore, the lack of inhibitory deficit on the CI in Bartels, Kunert [18], may relate to research showing that crossmodal stop signals are more effective at prompting response inhibition [41], perhaps due to higher salience [42], so possibly making this task type less able to capture inhibitory impairment in AUD. Finally, issues with using words recalled in the Stroop incongruent condition (as in Pitel, Rivier [27]) have already been discussed in the focused attention section.

1.2.5 Verbal fluency

Whilst verbal fluency was not statistically significantly impaired at baseline [21], it did demonstrate improvement consistently across the three studies, at 18 days [23], and one, three, [25] and 12 months [21]. Verbal fluency is often considered an executive function [31], but less consistently than the other measures [43], and it may be more driven by language processing [44], possibly explaining why this did not demonstrate impairment. While not confirmed using tests of significance, Angerville, Ritz [23] did find indications of initial verbal fluency impairment on AVF, however this is a more executive task than the others used as it involves flexibility, which is likely to explain the discrepancy. Furthermore, as mentioned previously, while specific function conclusions cannot be drawn, Angerville, Ritz [23], found that lower age of onset of first alcohol use and higher AUDIT score associated with poorer recovery of a composite cognitive score which included verbal fluency function.

1.2.6 Flexibility

Flexibility was generally impaired at baseline, though recovery was inconsistent, with follow-ups ranging from 14–18 days of abstinence to 12 months. The majority found an initial flexibility deficit, except for Czapla, Simon [19] and Alhassoon, Sorg [35], who found impairment on the Halstead Category Test (HCT), but not TMT-B. Impairment was generally consistent across studies during early recovery (between 18 days and three months) but was inconsistent beyond six months. Loeber, Duka [33], who did not compare to controls beyond baseline, and Ioime, Guglielmo [28] found improvement, even recovery [28] by this stage. However, at 12 months, two studies found continued impairment [21, 35], while individuals in Ioime, Guglielmo [28] maintained their recovery from six months.

Perhaps this suggests that flexibility in some individuals will recover by six months, and that there are predictors of the discrepancies that were not assessed but may also indicate that there is a risk that performance can improve and deteriorate again by 12 months. However, without more studies with multiple follow-ups, this trajectory remains unclear. Interestingly, Alhassoon, Sorg [35], who found maintained impairment at 12 months on the HCT, did not find initial impairment on the TMT-B (which has been discussed previously in relation to gender, in the divided attention section) perhaps indicating that at least in this cohort, the added element of concept formation and reasoning in HCT contributed to initial deficit on this executive measure. Additionally, as an exception, Angerville, Ritz [23] did find improvement by 18 ± 2 days, using AVF. This was the only verbal task assessing flexibility (and processing speed), again perhaps indicating faster improvement of verbal than visual functions.

It is unclear why Czapla, Simon [19] found no impairment on Intra-Extra Dimensional Set Shift (IED) extradimensional shift errors, given that this task is essentially analogous to the WCST and therefore similar to the Modified Card Sorting Test (MCST), and that all other studies using either of these, or even the IED itself, did find impairment [21, 28, 33], however, this was the latest baseline assessment of these, at 2–4 weeks of abstinence, which may have reduced the reliability of the assessment.

As mentioned previously, Loeber, Duka [33], who used a composite TMT-B/WCST measure, found that repeated cycles of abstinence/relapse, worsened outcomes in divided attention and cognitive flexibility by six months. Similarly, while Pitel, Rivier [27] found no initial impairment on the Flexibility task, they did find that individuals who relapsed before the six-month follow-up, then demonstrated worsened performance. Additionally, while specific function conclusions cannot be drawn, Angerville, Ritz [23], found that lower age of onset of first alcohol use and higher AUDIT score predicted poorer recovery of a composite cognitive score which included flexibility.

1.3 Concept formation & reasoning

Five studies assessed concept formation and reasoning abilities, three of which assessed visual concept formation, and four the ability to form a concept by which to sort stimuli, and then to switch and form/sort by a new concept. Follow-ups ranged from 1–12 months of abstinence. General concept formation and reasoning skills demonstrated consistent impairment, whilst recovery of sorting and shifting ability was inconsistent.

1.3.1 Visual concept formation

Visual concept formation and reasoning was both initially and consistently impaired, even up to 12 months. Follow-ups ranged from 6 months of abstinence to 12 months. This consistent impairment is logical given that reasoning abilities are often considered a good indicator of premorbid intelligence [14]. The exception was Manning, Wanigaratne [21], who used Matrix Reasoning (MR) combined with Vocabulary to create a Full-Scale IQ score and reported that the IQ score was in the normal range at baseline (but did not describe the range of MR itself), and that MR improved by 12 months. This conflicts with the findings of both Alhassoon, Sorg [35] and Ioime, Guglielmo [28], who found continued impairment on HCT, and Raven’s Progressive Matrices, at this abstinence period.

Interestingly, Ioime, Guglielmo [28] did find some improvement by both six and 12 months, but not recovery to control level. Furthermore, grouping of this construct should be considered, as despite it being considered a premorbid ability, some reviews on this topic have grouped it with functions that would be expected to improve, such as executive function [5, 6]. This may reduce the validity of the synthesis/analysis. Finally, while Schulte, Cousijn [7] concluded that ‘Performance IQ’ as the function of MR, improved with abstinence in AUD, a closer examination indicates that the only study to find this was Manning, Wanigaratne [21]. Therefore, when additional studies are considered, this seems to be a consistently impaired ability in abstinence from AD.

1.3.2 Sort and shift

The ability to sort and shift was impaired at baseline, and recovery was inconsistent. Follow-ups ranged from 1–12 months of abstinence. Kaur, Sidana [25], who did not compare to controls, indicated that there was some improvement of function on WCST by both one and three months, whilst Ioime, Guglielmo [28] found that MCST performance was fully recovered by both six and 12 months. In contrast, both Czapla, Simon [19] and Manning, Wanigaratne [21] found consistent impairment, at six and 12 months respectively, using IED. It seems that there may be some improvement, but it is unclear if this reaches control performance. Perhaps the modified form of the WCST is less able to monitor continued impairment in AUD, particularly as it simplifies the concept formation [45].

1.4 Learning & memory

Memory was assessed by ten studies, four of which assessed verbal STM, six assessed verbal LTM, six assessed visual STM, and five assessed visual LTM. One study only assessed STM as a composite score of visual and verbal ability, which will be discussed separately at the end of this section. Follow-ups ranged from 14–18 days of abstinence to 24 months. Typically, STM for both modalities demonstrated faster recovery than LTM, and despite verbal memory being indicated as recovering faster overall, it was more inclined to worsen during the first six months of abstinence, compared to visual. Visual LTM recovery was the slowest, generally not recovering until two years.

1.4.1 Verbal short-term memory

Verbal STM was generally impaired (except in Manning, Wanigaratne [21]), with recovery occurring from six months onwards in the majority. Follow-ups ranged from 1–12 months of abstinence. Durazzo, Pennington [15] indicated that performance worsened by one month in former and active smokers, but recovered fully by eight, which complements Pitel, Rivier [27] who found full recovery by six months. However, Ioime, Guglielmo [28] found that deficits persisted at both six and 12 months, despite Manning, Wanigaratne [21] finding improvement at 12.

1.4.2 Verbal long-term memory

Verbal LTM was consistently impaired at baseline (except in Durazzo) but recovered in the majority by eight months. Follow-ups ranged from 18 days to 24 months of abstinence. While Angerville, Ritz [23] found improvement by 18 ± 2 days, both Durazzo, Pennington [15] and Ioime, Guglielmo [28] both found worsening of performance, at one and six months respectively, and only in active smokers in the former. There was inconsistency at six months, as alongside Ioime, Guglielmo [28] finding worsening, the cohort in Pitel, Rivier [27] had fully recovered, while Bartels, Kunert [18] found continued impairment, suggesting that impairment is still likely at this stage. Beyond this, full recovery was consistent at eight [15], 12 [18, 21], and 24 months [18], except for Ioime, Guglielmo [28] who still found impairment at 12 months.

It is worth noting that Ioime, Guglielmo [28] was the only study that found impairment in both verbal short- and long-term memory at 12 months, using the Rey Auditory Verbal Learning Test (RAVL) indicating perhaps that this was specific to their cohort. Indeed, it is possible that verbal memory recovery slope/extent is driven by confounding factors. Durazzo, Pennington [15] again found that age and premorbid verbal intelligence independently predicted change across the whole sample, as did education. Additionally, differential rates of impairment and change were found regarding smoking status, with active/former smokers (and greater lifetime years of smoking) driving initial impairment and showing poorer recovery. Also, both active/former smokers recovered more poorly with increasing age, further highlighting the importance of age as a predictor. Furthermore, as previously mentioned, Angerville, Ritz [23], found that lower age of onset of first alcohol use and higher AUDIT score associated with poorer recovery of a composite cognitive score which included verbal long-term memory.

1.4.3 Visual short-term memory

Visual STM was consistently impaired at baseline, recovered by eight months onwards [15, 18, 28] and maintained at 24 months [18]. Exceptions were Wegner, Günthner [36], who used a simple delayed vernier discrimination task and may therefore have been unable to capture group differences, and Petit, Luminet [20], who found recovery on the Brown-Peterson technique by 14–18 days. It is unclear why function was recovered so early in Petit, Luminet [20], however as they also tested controls twice during the same interval, it is unlikely due to practice effects. Follow-ups ranged from 14–18 days of abstinence to 24 months.

1.4.4 Visual long-term memory

Visual LTM was consistently impaired at baseline, with recall also consistently impaired at 12 months [18, 28, 35], and signs of complete recovery not evident until 24 months [18]. However Durazzo, Pennington [15], found recovery at eight months (though not in active smokers), and Yeh, Gazdzinski [46], found improvement at one and seven months. Follow-ups ranged from 1–24 months of abstinence.

Once again, age and premorbid verbal intelligence independently predicted change across the whole sample [15]. Both Durazzo, Pennington [15] and Yeh, Gazdzinski [46] found differential recovery as a result of smoking status, with poorest initial performance and outcomes in former and active smokers, the latter of which did not recover to the level of controls [15]. Furthermore, again, both smoking groups demonstrated poorer recovery with increasing age. Yeh, Gazdzinski [46] also investigated brain volume, finding that gains in STM correlated negatively in smokers with brain volume increases during one month of abstinence, which they suggested may indicate that these structural brain changes are pathological.

One extra study that assessed memory did not report memory task outcomes individually. Loeber, Duka [33] created a composite measure of visual and verbal STM (number of pictures remembered on Benton Visual Retention Test, and words remembered on RAVL). This study was an outlier, as it did not find initial impairment, or change of this memory function across three or six months, perhaps indicating that a composite measure is less valid.

1.5 Perception and motor performance

Only five studies assessed visual perception, three of which also assessed figure and design reproduction (drawing, an indicator of fine motor function). One study measured visual interference, and one further study assessed fine motor function alone, which is synthesised here also. Follow-ups ranged from 18 days to 12 months of abstinence. It seems that fine motor function and perception of simple designs and visual interference generally responds well to abstinence, improving or even recovering by 6 months. In contrast, perception of more complex designs requires up to 12 months to recover.

Indeed, the earliest improvement was perception of visual interference, which had improved by 18 ± 2 days [23], while recognition and reproduction of complex figures was still impaired by six months but did recover by 12 [28]. All other tasks involved copying much simpler designs (perception and fine motor performance), which showed recovery by six and 12 months [28], or demonstrated improvement consistently at one and three months [25]. Furthermore, Motor Screening Test performance was not impaired at a baseline assessment of two weeks [21]. Emotional expression recognition was impaired in both accuracy of emotion judgement, and judgement of emotion intensity, in AUD versus controls [47], which did not recover by three months of abstinence. Due to the lack of studies assessing emotional decoding, it is difficult to synthesise this finding, and it is unclear how long recovery would take. Regarding predictors, while specific function conclusions cannot be drawn, Angerville, Ritz [23], found that lower age of onset and higher AUDIT score associated with poorer recovery of a composite cognitive score which included visual interference.

1.6 Verbal function

Only one study assessed verbal knowledge [21], finding an improvement by one month of abstinence. While this was not directly compared to normal performance, it was combined with MR to form an IQ measure, which was in the normal range at baseline. It is not possible to synthesise much from this given the single study, however these results show that at least in this cohort, vocabulary was likely unimpaired in early abstinence, but demonstrated improvement regardless.

Discussion

The aim of this review was to examine recovery of neuropsychological function following abstinence in AUD, with the expectation being that every domain assessed would likely be impaired upon baseline testing, but that recovery would differ between domains and even sub-domains. These expectations were generally met. Overall, sub-domains within attention, EF, perception, and memory, generally demonstrate recovery between 6–12 months, though basic processing speed recovers within a month, and working memory updating/tracking as early as 18 days, while verbal function demonstrated improvement within a month, but was likely unimpaired to start with.

Specifically, attention recovered by 12 months at the latest, with sub-domains recovering earlier: basic processing speed by a month (longer if more complex tasks used), divided attention by six months, and focused attention by 6–12 months. Attentional capacity was seemingly unimpaired, with some initial poor performance likely due to working memory updating/tracking aspects of tasks used. Executive functions recovered differentially, with working memory updating/tracking recovering by 18 days, response inhibition by six months, and decision-making demonstrating improvement by six months. Recovery of flexibility was inconsistent up to 12 months, while planning was still impaired at this stage. Verbal fluency was not indicated as impaired but did improve consistently nonetheless over the course of 12 months. Within learning and memory, STM recovered faster than LTM, as did verbal compared to visual. Verbal STM recovered by six months onwards, while verbal LTM took up to eight months. Visual STM recovered by eight months onwards, while visual LTM took 24 months. Perception and motor performance responded well to abstinence, with improvement or recovery generally indicated by six months, though with few studies synthesised, this is uncertain. Within this, perception of visual interference improved by 18 days, while perception (and fine motor skills) of simple figures recovered by six months, and perception of more complex designs took up to 12 months (similarly, emotional facial expression was still impaired at three months). Fine motor skills were likely unimpaired, but recovered by six months if so. In contrast to the displays of improvement or recovery, by 12 months, general concept formation and reasoning skills were consistently impaired, whilst recovery of sorting and shifting ability was inconsistent.

That most of the domains and sub-domains assessed were generally initially impaired (with the exception of verbal fluency and attentional capacity) supports previous research that has found the same [57, 48], while differential recovery of executive functions supports that these are separable abilities [49]. When compared to Schulte, Cousijn [7], who also reviewed longitudinal literature, the current review similarly found recovery of verbal memory, response inhibition, and continued impairment of emotional facial expression recognition and planning. In contrast, Schulte, Cousijn [7] found no improvement in decision making, focused attention, or verbal functions, but did find improvement in reasoning ability. However, only two studies in Schulte, Cousijn [7] measured concept formation and reasoning (called Performance IQ in Schulte, Cousijn [7]), one was Manning, Wanigaratne [21], included in the current review, and the other Rosenbloom, Rohlfing [50], which was excluded here due to a very varied initial abstinence at baseline, ranging from three weeks to two years, as it was determined that it could not be considered an assessment of the impact of abstinence duration. Furthermore, only two studies in Schulte, Cousijn [7] assessed decision-making [22, 33], both of which are in the current review, while an additional study included here [19] was published later, giving further insight. Similarly, three studies in Schulte, Cousijn [7] assessed focused attention (called Sustained Attention), one among the seven included here [27], Rosenbloom, Rohlfing [50], excluded for the reasons described, and Sullivan, Rosenbloom [51], excluded from the current review due to using the DSM-III-R to identify AUD participants, which has good concordance with the DSM-IV and ICD-10 [52], but is slightly different [53] and so could capture a different group to more recent tools. Finally, verbal function (called Verbal IQ) was assessed by two studies in Schulte, Cousijn [7], Fujiwara, Brand [54], who examined ARBI patients (a different group), and Rosenbloom, Rohlfing [50], though it should be noted that the current review only described one study of verbal function, which is not at all conclusive.

In relation to neural correlates, inhibitory control, flexibility, working memory, planning, decision making, attention, reasoning, processing speed, verbal short- and long-term memory, are all arguably functions depending heavily on frontoparietal regions, particularly the PFC [5559]. Exceptions include fine motor function which associates with frontal and cerebellar regions [60], perception which is frontoparietal and occipital [61], verbal fluency which is largely frontal [57], visual STM which is occipito-parietal, visual LTM which associates with the medial temporal lobe and hippocampus [62], vocabulary which involves frontal, temporal, thalamic, and cerebellar regions [63], and emotion recognition which associates with visual and limbic systems, prefrontal, temporoparietal, and subcortical areas such as the cerebellum [64].

The current findings of initial impairment therefore are in line with grey matter alterations in AUD which have been found consistently in parts of the PFC, anterior cingulate cortex, and insulae in AUD [2, 3, 6568], in various frontal and parietal areas [2, 3, 67] and subcortical regions such as the thalamus, hippocampus and cerebellum [3, 67], along with widespread white matter reductions [1, 3] which are most pronounced in the frontal lobes, cerebellum, and limbic system [3]. Furthermore, that there were relatively consistent improvements, even to the point of recovery, of various sub-domains within attention, executive function, memory, and perception, supports findings of Zou, Durazzo [69] that the volumes of the anterior cingulate cortex, dorsolateral PFC, orbitofrontal cortex, and insula reached equivalent volume to controls by seven months of abstinence, while the hippocampal volume increased but still remained smaller than controls, perhaps explaining the slower recovery of visual LTM compared to other types of memory in this review. However, Durazzo, Mon [16] found that lobar and cerebellar brain volume increases associated with processing speed recovery only, not that of verbal or visual memory.

Relating to the impact of alcohol on the brain, impairment and recovery of many of these functions upon abstinence appears to support that the frontal lobe and cerebral cortex are particularly vulnerable to damage by active AUD (the frontal lobe vulnerability, and whole brain hypotheses; Oscar-Berman and Marinkovic [70]), though it is likely that elements of cognitive function may be heritable and have a cyclical relationship with alcohol [71]. Given that the frontal lobes have rich connections with other brain regions, and that prefrontal functions are required for cognitive control, damage to this area may therefore influence performance on tests used for assessing functions of other brain regions [72]. Furthermore, given that Durazzo, Pennington [15] found that age independently predicted recovery on processing speed, attentional capacity, and memory, this supports the ‘premature aging hypothesis’, which posits that alcohol either ages the brain prematurely, or that age increases the vulnerability of the brain to alcohol [70, 73, 74].

With regards to the second aim of this review, various predictors were indicated for several domains/sub-domains. A consistent predictor of recovery was age, which predicted recovery of processing speed, attentional capacity, and memory [15], as did smoking status, and premorbid verbal intelligence (Vocabulary Test; Schmidt and Metzler [39]), while verbal memory was also predicted by education. Additionally, in smokers, visual short term memory recovery negatively associated with potentially pathological increases in brain volume [46]. A reduction of drinking behaviour in people important to the individual supported recovery of focused attention [29], while divided attention recovered more poorly with repeated cycles of withdrawal and relapse [33]. Finally, lower age of onset of first alcohol use and higher AUDIT score both associated with poorer recovery of a composite cognitive score [23], though more research is needed to understand how recovery of specific functions is impacted by these factors. Despite this, future research and intervention should try to consider all these predictive elements to ensure that best outcomes can be achieved for everyone.

Robustness of synthesis

Study quality was assessed using the JBI Checklist for Cohort Studies (Moola, Munn [75], see Table 3). The majority (eleven) of studies were classed as ‘good’, allowing for relative trustworthiness of the current review, while three were considered ‘moderate’, and two were ‘poor’. The most frequent issues throughout the literature reviewed were not including controls, confirming abstinence using self-report only, assessing function up to less than six months of abstinence (given that previous research suggested function may take up to a year to recover [6]), limited description of the characteristics of those lost to attrition, lack of strategies to reduce attrition bias, and not controlling for potential confounds in the statistical analysis. Furthermore, ultimately, as Schulte, Cousijn [7] stated, without studies that assess neuropsychological functioning before, during, and after AUD, there is less certainty about the findings with regards to the relationship of alcohol use to function at each of these stages. These issues should all be considered in future research.

Table 3. Quality assessment using JBI checklist for cohort studies.

Author 1. Were the two groups similar and recruited from the same population? 2. Were the exposures measured similarly to assign people to both exposed and unexposed groups? 3. Was the exposure measured in a valid and reliable way? 4. Were confounding factors identified? 5. Were strategies to deal with confounding factors stated? 6. Were the groups/ participants free of the outcome at the start of the study (or at the moment of exposure)? 7. Were the outcomes measured in a valid and reliable way? 8. Was the follow up time reported and sufficient to be long enough for outcomes to occur? 9. Was follow up complete, and if not, were the reasons for loss to follow up described and explored? 10. Were strategies to address incomplete follow up utilized? 11. Was appropriate statistical analysis used? Quality Score (%)
Poor ≤ 49 Moderate =
50–69
Good ≥ 70
Alhassoon et al., 2012 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 100
Angerville et al. 2023 Yes Yes Yes Yes Yes Yes Unclear Yes Yes Yes 90
Bartels et al., 2007 Not applicable Not applicable Yes Yes Yes Yes Yes Yes Yes No 70
Czapla et al., 2016 Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 100
Cordovil De Sousa Uva et al., 2010 Yes Yes Yes Yes Yes Yes Unclear No No Yes 70
Durazzo et al., 2014 Not applicable Not applicable Yes Yes Yes Yes Yes Yes Yes Yes 80
Foisy et al., 2007 Yes Yes Yes Yes Yes Yes Unclear Yes No Yes 80
Ioime et al., 2018 Yes Yes Yes Yes Yes Yes Yes Yes Yes No 90
Kaur et al., 2020 Not applicable Not applicable No Yes Yes Yes Unclear Unclear Unclear Unclear 30
Loeber et al., 2010 Yes Yes Yes Yes Yes Yes Yes Yes No Yes 90
Manning et al., 2008 Not applicable Not applicable Yes Yes Unclear Yes Unclear Unclear Unclear Yes 40
McCutcheon et al., 2016 Not applicable Not applicable No Yes Yes Yes Unclear Yes Yes Yes 60
Petit et al., 2017 Yes Yes Yes Yes Yes Yes Unclear Unclear No Yes 70
Pitel et al., 2009 Yes Yes No Yes Yes Yes Yes Yes Yes No 80
Wegner et al., 2001 Yes Yes Yes Yes Yes Yes Unclear Unclear Unclear Yes 70
Yeh et al., 2007 Not applicable Not applicable No Yes Yes Yes Yes No Yes Yes 60

Note: due to the nature of this review, some checklist questions were not directly applicable. Therefore, question one was answered “Yes” if a control and AUD group were matched or described as similar on age, gender, or education. Question two was answered “Yes” if it was made clear that controls did not have a diagnosis of AUD. Question three was answered “Yes” if abstinence from alcohol was confirmed in AUD participants at each time, using additional methods to self-report (except for follow-ups conducted in inpatient settings where abstinence would be assured). Question six was not relevant as the outcome was neuropsychological change upon maintenance of abstinence in AUD rather than an incidence of illness, so this question was not used to assess study quality. Based on previous literature, question eight was answered “Yes” if the study followed up to six months of abstinence or longer. Question ten in the checklist suggested methods such as calculating person-years at risk, which again is not suitable for studies in this review, therefore this question was answered “Yes” if follow-up was complete, or if studies used statistical methods such as linear mixed modelling, multiple imputation, dummy variables, or sample weights. Alternatively, complete case analysis was deemed acceptable when characteristics of those lost to follow-up were like those who remained. Finally, question 11 was answered “Yes” if the statistical analysis used adjusted in some way for covariates/ confounds, or multiple dependent variables (if appropriate considering outcomes measured) including use of multivariate analysis or Bonferroni correction.

Two of the ‘moderate’ quality studies [29, 46], and one of the ‘poor’ [25], did not compare to controls or normative data, and so were only considered as information on improvement within the review, not as direct assessment of recovery. Furthermore, as a safeguard to the quality of the review, despite Kaur, Sidana [25] reporting on predictors of cognitive recovery, these were not included, as the nature of statistical analyses and findings were unclear and contradictory throughout this source. Similarly, while Angerville, Ritz [23] (good) did include controls and normative data in their study design, this paper has been used here to infer improvement only (not recovery) due to a lack of comparison using tests of statistical significance at T0 to either normative data or to controls (despite indications of initial impairment). Improvement was measured via regression methods assessing the impact of abstinence duration, and therefore this has been synthesised.

Manning, Wanigaratne [21] (poor) and Cordovil De Sousa Uva, Luminet [22] (moderate) however did include appropriate performance comparisons, and so any conclusions drawn because of their inclusion may need caution in interpretation. In particular, those relating to Manning, Wanigaratne [21], such as within planning, verbal fluency, and verbal function, for which this was the only study at all to assess comparative to normative data. This study was also at odds with other papers regarding absence of initial impairment for processing speed, working memory updating/tracking, visual concept formation, verbal STM, and fine motor function; however as multiple studies opposed this, these findings were considered the exception. Similarly, most sub-domains and domains were assessed by three or more studies, except for planning, verbal fluency, and verbal function (which are also those contributed to most significantly by Manning, Wanigaratne [21]), suggesting that all functions except these, the synthesis results are trustworthy regarding the quantity and quality of evidence.

A strength of this is review is the grouping of tasks under multiple functions (as opposed to Crowe, Cammisuli [5], Stavro, Pelletier [6]), as it is recognised that multiple tasks span various domains and sub-domains [7], and indeed that specific elements of each task may measure different abilities (as described in Table 2). Additionally, the review considers the predictive features contributing to the variance in recovery, though a limitation is the inability to control for confounds such as practice effects, medication, and comorbid health problems, particularly comorbid psychiatric or gastrointestinal and liver disorders (such as cirrhosis) which are highly comorbid in AUD [76, 77] and along with the related treatment (e.g., psychotropic medications) also impact cognitive function [7880]. the reality is that in populations recovering from AUD, medication and comorbid health problems are likely to be the norm [77], suggesting that these are less isolated contributions to variance, though liver disease and psychotropic medications would be useful criteria to exclude where feasible.

The authors used various methods to strengthen the quality of this narrative synthesis by reducing bias, including pre-registering the protocol with PROSPERO, publishing the protocol so as to gain valuable feedback prior to conducting the review [11], limiting to only DSM-IV/5 and ICD-10/11 to try to ensure comparative cohorts [81], full-text screening being checked by multiple reviewers, and 10% of quality assessment being independently conducted.

Future research and implications for practice

Future research into neuropsychological recovery from AUD should consider the impacts of age, premorbid intelligence, smoking, education, brain volume, number of previous treatments, and drinking behaviour of those close to the individual, as all were identified as predictors [15, 29, 33], so could explain some of the variance identified across the literature. Large scale prospective studies are also needed to understand what functional differences compared to controls may be pre-existing, and how this may be cyclical, as some are likely to have causal relationships with AUD [82, 83].

Interestingly, in the RVP task, which required a combination of multiple executive or executive and reasoning abilities, initial and continued impairment was more likely than in tasks that were more function specific. This indicates that to capture impairment, the additive nature of task requirements should be considered in future research, particularly as day-to-day demands are likely to be competing for cognitive resource in this way. Indeed, in the development of their virtual reality ‘Jansari assessment of Executive Functions’, Jansari, Devlin [84] suggested that assessing individual EF is like a conductor listening to individual instruments of an orchestra to decide if they work together, when listening to them in harmony would give a more ecologically sound understanding of ability. Additionally, in a study of a dual working memory updating (N-back) and response inhibition (Flanker) task, Kim, Wittenberg [55] found that increasing the working memory load led to a decrease in both working memory and response inhibition performance, indicating an interaction effect of the two EFs on individual task performance. Furthermore, Finn, Justus [85] suggest that individuals with low working memory capacity are more susceptible to a reduction in inhibitory control due to alcohol, suggesting a complex interaction between alcohol use and the additive impact of cognitive functions, which should be further investigated in the context of recovery. In addition, there was some evidence that certain verbal functions recover faster than visual (specifically relating to processing speed, flexibility, and memory), which is something that should be studied further, as it may account for some of the discrepancies within the literature. Of the studies reviewed here, there were large discrepancies between the timeline of assessment, which weakens the comparisons that can be made. To combat this, future studies should seek to capture regular follow-up assessments up to and beyond at least a year of abstinence.

Importantly, this review indicates that several functions do recover with prolonged abstinence from alcohol in individuals with AUD. This information may be encouraging for patients, and therefore could be provided to them by practitioners in a plain language format (e.g., in the form of motivational interviewing techniques), to help them engage in and maintain recovery behaviours. The impact of this could also be investigated, as to whether knowledge of this information improves maintenance of abstinence.

Conclusions

The findings of this systematic review suggest that sub-domains within attention, executive function, perception, and memory, demonstrate recovery, generally between 6–12 months. This supports both the frontal lobe vulnerability and whole brain hypotheses of alcohol damage, while the consistent finding of age as a predictor of function recovery supports the premature aging hypothesis. Overall robustness of results was deemed good, though not for planning, verbal fluency, and verbal function, for which further research addressing previous methodological limitations is required, which include lack of control groups, additional methods to self-report to confirm abstinence, description/control for attrition, statistical control of confounds, and of long enough study durations to capture change. Future research should consider the impacts of identified predictors, as these may explain some of the variance across the literature. Large scale prospective studies will develop our understanding of what functional differences may be pre-existing or cyclical. Finally, the additive nature of task requirements in cognitive recovery should be investigated, particularly as day-to-day demands are likely to be layered. With regards to implications for practice, practitioners should consider delivering to patients the finding that cognitive recovery in several functions can be achieved with abstinence, as this may provide encouragement and support positive behaviour change. The impact of such delivery on maintenance of abstinence could also be assessed.

Supporting information

S1 Table. PRISMA 2020 abstracts checklist.

(PDF)

S2 Table. PRISMA 2020 checklist.

(PDF)

S3 Table. Systematic search strategies for APA PsycInfo, EBSCO MEDLINE, CINAHL, and Web of Science.

(PDF)

S4 Table. Papers excluded at the full-text screening stage, with reason for exclusion.

(PDF)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Monnig MA, Tonigan JS, Yeo RA, Thoma RJ, McCrady BS. White matter volume in alcohol use disorders: a meta‐analysis. Addict Biol. 2013;18(3):581–92. doi: 10.1111/j.1369-1600.2012.00441.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Spindler C, Trautmann S, Alexander N, Bröning S, Bartscher S, Stuppe M, et al. Meta-analysis of grey matter changes and their behavioral characterization in patients with alcohol use disorder. Sci Rep. 2021;11(1):1–15. doi: 10.1038/s41598-021-84804-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bühler M, Mann K. Alcohol and the human brain: a systematic review of different neuroimaging methods. Alcohol Clin Exp Res. 2011;35(10):1771–93. doi: 10.1111/j.1530-0277.2011.01540.x [DOI] [PubMed] [Google Scholar]
  • 4.Hamidovic A, Wang Y. The P300 in alcohol use disorder: A meta-analysis and meta-regression. Prog Neuropsychopharmacol Biol Psychiatry. 2019;95:109716. doi: 10.1016/j.pnpbp.2019.109716 [DOI] [PubMed] [Google Scholar]
  • 5.Crowe SF, Cammisuli DM, Stranks EK. Widespread Cognitive Deficits in Alcoholism Persistent Following Prolonged Abstinence: An Updated Meta-analysis of Studies That Used Standardised Neuropsychological Assessment Tools. Arch Clin Neuropsychol. 2019. doi: 10.1093/arclin/acy106 [DOI] [PubMed] [Google Scholar]
  • 6.Stavro K, Pelletier J, Potvin S. Widespread and sustained cognitive deficits in alcoholism: a meta-analysis. Addict Biol. 2012;18(2):203–13. doi: 10.1111/j.1369-1600.2011.00418.x [DOI] [PubMed] [Google Scholar]
  • 7.Schulte MHJ, Cousijn J, den Uyl TE, Goudriaan AE, van den Brink W, Veltman DJ, et al. Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment. Clin Psychol Rev. 2014;34(7):531–50. doi: 10.1016/j.cpr.2014.08.002 [DOI] [PubMed] [Google Scholar]
  • 8.Bora E, Zorlu N. Social cognition in alcohol use disorder: a meta‐analysis. Addiction. 2017;112(1):40–8. doi: 10.1111/add.13486 [DOI] [PubMed] [Google Scholar]
  • 9.Domínguez-Salas S, Díaz-Batanero C, Lozano-Rojas OM, Verdejo-García A. Impact of general cognition and executive function deficits on addiction treatment outcomes: Systematic review and discussion of neurocognitive pathways. Neurosci Biobehav Rev. 2016;71:772–801. doi: 10.1016/j.neubiorev.2016.09.030 [DOI] [PubMed] [Google Scholar]
  • 10.Brion M D ’Hondt F, Pitel A-L, Lecomte B, Ferauge M, de Timary P, et al. Executive functions in alcohol-dependence: A theoretically grounded and integrative exploration. Drug Alcohol Depend. 2017;177:39–47. doi: 10.1016/j.drugalcdep.2017.03.018 [DOI] [PubMed] [Google Scholar]
  • 11.Powell A, Sumnall H, Smith J, Kuiper R, Montgomery C. Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: Protocol for a systematic review of longitudinal studies. PLoS One. 2022;17(9):e0274752. Epub 2022/09/30. doi: 10.1371/journal.pone.0274752 ; PubMed Central PMCID: PMC9521940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme Version. 2006;1:b92. doi: 10.13140/2.1.1018.4643 [DOI] [Google Scholar]
  • 13.Centre for Reviews and Dissemination. Systematic reviews: CRD’s guidance for undertaking reviews in healthcare. York: University of York NHS Centre for Reviews & Dissemination. 2009. [Google Scholar]
  • 14.Lezak MD, Howieson DB, Bigler ED, Tranel D. Neuropsychological assessment, 5th ed. New York, NY, US: Oxford University Press; 2012. xxv, 1161–xxv, p. [Google Scholar]
  • 15.Durazzo TC, Pennington DL, Schmidt TP, Meyerhoff DJ. Effects of cigarette smoking history on neurocognitive recovery over 8 months of abstinence in alcohol‐dependent individuals. Alcohol Clin Exp Res. 2014;38(11):2816–25. doi: 10.1111/acer.12552 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Durazzo TC, Mon A, Gazdzinski S, Yeh P-H, Meyerhoff DJ. Serial longitudinal MRI data indicates non-linear regional gray matter volume recovery in abstinent alcohol dependent individuals. Addict Biol. 2015;20(5):956. doi: 10.1111/adb.12180 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Pennington DL, Durazzo TC, Schmidt TP, Mon A, Abé C, Meyerhoff DJ. The effects of chronic cigarette smoking on cognitive recovery during early abstinence from alcohol. Alcohol Clin Exp Res. 2013;37(7):1220–7. doi: 10.1111/acer.12089 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bartels C, Kunert H-J, Stawicki S, Kröner-Herwig B, Ehrenreich H, Krampe H. Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence. Alcohol Alcohol. 2007;42(2):92–102. doi: 10.1093/alcalc/agl104 [DOI] [PubMed] [Google Scholar]
  • 19.Czapla M, Simon JJ, Richter B, Kluge M, Friederich H-C, Herpertz S, et al. The impact of cognitive impairment and impulsivity on relapse of alcohol-dependent patients: implications for psychotherapeutic treatment. Addict Biol. 2015;21(4):873–84. doi: 10.1111/adb.12229 [DOI] [PubMed] [Google Scholar]
  • 20.Petit G, Luminet O, Cordovil de Sousa Uva M, Zorbas A, Maurage P, de Timary P. Differential spontaneous recovery across cognitive abilities during detoxification period in alcohol-dependence. PLOS ONE. 2017;12(8):e0176638. doi: 10.1371/journal.pone.0176638 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Manning V, Wanigaratne S, Best D, Hill R, Reed L, Ball D, et al. Changes in neuropsychological functioning during alcohol detoxification. European addiction research. 2008;14(4):226–33. doi: 10.1159/000156479 [DOI] [PubMed] [Google Scholar]
  • 22.Cordovil De Sousa Uva M, Luminet O, Cortesi M, Constant E, Derely M, De Timary P. Distinct effects of protracted withdrawal on affect, craving, selective attention and executive functions among alcohol-dependent patients. Alcohol & Alcoholism. 2010;45(3):241–6. doi: 10.1093/alcalc/agq012 [DOI] [PubMed] [Google Scholar]
  • 23.Angerville B, Ritz L, Pitel A-L, Beaunieux H, Houchi H, Martinetti MP, et al. Early Improvement of Neuropsychological Impairments During Detoxification in Patients with Alcohol Use Disorder. Alcohol Alcohol. 2023;58(1):46–53. doi: 10.1093/alcalc/agac048 [DOI] [PubMed] [Google Scholar]
  • 24.Gerton BK, Brown TT, Meyer-Lindenberg A, Kohn P, Holt JL, Olsen RK, et al. Shared and distinct neurophysiological components of the digits forward and backward tasks as revealed by functional neuroimaging. Neuropsychologia. 2004;42(13):1781–7. doi: 10.1016/j.neuropsychologia.2004.04.023 [DOI] [PubMed] [Google Scholar]
  • 25.Kaur P, Sidana A, Malhotra N, Gupta A. Effects of abstinence of alcohol on neurocognitive functioning in patients with alcohol dependence syndrome. Asian Journal of Psychiatry. 2020;50:101997. doi: 10.1016/j.ajp.2020.101997 [DOI] [PubMed] [Google Scholar]
  • 26.Donolato E, Giofrè D, Mammarella IC. Differences in verbal and visuospatial forward and backward order recall: A review of the literature. Frontiers in Psychology. 2017;8:663. doi: 10.3389/fpsyg.2017.00663 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Pitel AL, Rivier J, Beaunieux H, Vabret F, Desgranges B, Eustache F. Changes in the episodic memory and executive functions of abstinent and relapsed alcoholics over a 6‐month period. Alcohol Clin Exp Res. 2009;33(3):490–8. doi: 10.1111/j.1530-0277.2008.00859.x [DOI] [PubMed] [Google Scholar]
  • 28.Ioime L, Guglielmo R, Affini GF, Quatrale M, Martinotti G, Callea A, et al. Neuropsychological performance in alcohol dependent patients: A one-year longitudinal study. Psychiatry Investig. 2018;15(5):505. doi: 10.30773/pi.2017.09.27.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.McCutcheon VV, Luke DA, Lessov‐Schlaggar CN. Reduced social network drinking is associated with improved response inhibition in women during early recovery from alcohol use disorders: a pilot study. Alcohol Clin Exp Res. 2016;40(1):170–7. doi: 10.1111/acer.12925 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Scarpina F, Tagini S. The Stroop Color and Word Test. 2017;8:557. Epub 2017/04/28. doi: 10.3389/fpsyg.2017.00557 Front Psychol. ; PubMed Central PMCID: PMC5388755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Diamond A. Executive functions. Annual review of psychology. 2013;64:135–68. doi: 10.1146/annurev-psych-113011-143750 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bates ME, Lemay EP. The d2 Test of attention: construct validity and extensions in scoring techniques. Journal of the International Neuropsychological Society. 2004;10(3):392–400. doi: 10.1017/S135561770410307X [DOI] [PubMed] [Google Scholar]
  • 33.Loeber S, Duka T, Welzel Márquez H, Nakovics H, Heinz A, Mann K, et al. Effects of repeated withdrawal from alcohol on recovery of cognitive impairment under abstinence and rate of relapse. Alcohol Alcohol. 2010;45(6):541–7. doi: 10.1093/alcalc/agq065 [DOI] [PubMed] [Google Scholar]
  • 34.Wegner E, Burkhart C, Weinhuber M, Nückles M. What metaphors of learning can (and cannot) tell us about students’ learning. Learning and Individual Differences. 2020;80:101884. doi: 10.1016/j.lindif.2020.101884 [DOI] [Google Scholar]
  • 35.Alhassoon OM, Sorg SF, Taylor MJ, Stephan RA, Schweinsburg BC, Stricker NH, et al. Callosal white matter microstructural recovery in abstinent alcoholics: a longitudinal diffusion tensor imaging study. Alcohol Clin Exp Res. 2012;36(11):1922–31. doi: 10.1111/j.1530-0277.2012.01808.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Wegner A-J, Günthner A, Fahle M. Visual performance and recovery in recently detoxified alcoholics. Alcohol Alcohol. 2001;36(2):171–9. doi: 10.1093/alcalc/36.2.171 [DOI] [PubMed] [Google Scholar]
  • 37.Płotek W, Łyskawa W, Kluzik A, Grześkowiak M, Podlewski R, Żaba Z, et al. Evaluation of the Trail Making Test and interval timing as measures of cognition in healthy adults: comparisons by age, education, and gender. Medical science monitor: international medical journal of experimental and clinical research. 2014;20:173. doi: 10.12659/MSM.889776 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Foroozandeh E. Gender differences in trail making test performance in a nonclinical sample of adults. Int J Clin Exp Neurol. 2014;2(1):1–3. doi: 10.12691/ijcen-2-1-1 [DOI] [Google Scholar]
  • 39.Schmidt K, Metzler P. WST-Wortschatztest. Göttingen: Beltz Test. 1992;16. [Google Scholar]
  • 40.Scaife JC, Duka T. Behavioural measures of frontal lobe function in a population of young social drinkers with binge drinking pattern. Pharmacol Biochem Behav. 2009;93(3):354–62. doi: 10.1016/j.pbb.2009.05.015 [DOI] [PubMed] [Google Scholar]
  • 41.Friehs MA, Schmalbrock P, Merz S, Dechant M, Hartwigsen G, Frings C. CrossModal Stopping. 2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Carrillo-de-la-Peña MT, Bonilla FM, González-Villar AJ. Effect of the stop-signal modality on brain electrical activity associated with suppression of ongoing actions. Biological psychology. 2019;143:85–92. doi: 10.1016/j.biopsycho.2019.01.010 [DOI] [PubMed] [Google Scholar]
  • 43.Gustavson DE, Panizzon MS, Franz CE, Reynolds CA, Corley RP, Hewitt JK, et al. Integrating verbal fluency with executive functions: Evidence from twin studies in adolescence and middle age. J Exp Psychol Gen. 2019;148(12):2104–19. Epub 2019/03/22. doi: 10.1037/xge0000589 ; PubMed Central PMCID: PMC6754807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Whiteside DM, Kealey T, Semla M, Luu H, Rice L, Basso MR, et al. Verbal Fluency: Language or Executive Function Measure? Appl Neuropsychol Adult. 2016;23(1):29–34. Epub 2015/06/26. doi: 10.1080/23279095.2015.1004574 . [DOI] [PubMed] [Google Scholar]
  • 45.Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex. 1976;12(4):313–24. doi: 10.1016/s0010-9452(76)80035-4 [DOI] [PubMed] [Google Scholar]
  • 46.Yeh P-H, Gazdzinski S, Durazzo TC, Sjöstrand K, Meyerhoff DJ. Hierarchical linear modeling (HLM) of longitudinal brain structural and cognitive changes in alcohol-dependent individuals during sobriety. Drug Alcohol Depend. 2007;91(2–3):195–204. doi: 10.1016/j.drugalcdep.2007.05.027 [DOI] [PubMed] [Google Scholar]
  • 47.Foisy ML, Kornreich C, Fobe A, D’Hondt L, Pelc I, Hanak C, et al. Impaired emotional facial expression recognition in alcohol dependence: do these deficits persist with midterm abstinence? Alcohol Clin Exp Res. 2007;31(3):404–10. doi: 10.1111/j.1530-0277.2006.00321.x [DOI] [PubMed] [Google Scholar]
  • 48.Stephan RA, Alhassoon OM, Allen KE, Wollman SC, Hall M, Thomas WJ, et al. Meta-analyses of clinical neuropsychological tests of executive dysfunction and impulsivity in alcohol use disorder. Am J Drug Alcohol Abuse. 2017;43(1):24–43. doi: 10.1080/00952990.2016.1206113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Miyake A, Friedman NP. The nature and organization of individual differences in executive functions: Four general conclusions. Current directions in psychological science. 2012;21(1):8–14. doi: 10.1177/0963721411429458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Rosenbloom MJ, Rohlfing T, O’Reilly AW, Sassoon SA, Pfefferbaum A, Sullivan EV. Improvement in memory and static balance with abstinence in alcoholic men and women: Selective relations with change in brain structure. Psychiatry Research: Neuroimaging. 2007;155(2):91–102. doi: 10.1016/j.pscychresns.2006.12.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Sullivan EV, Rosenbloom MJ, Lim KO, Pfefferbaum A. Longitudinal changes in cognition, gait, and balance in abstinent and relapsed alcoholic men: relationships to changes in brain structure. Neuropsychology. 2000;14(2):178. doi: 10.1037/0894-4105.14.2.178 [DOI] [PubMed] [Google Scholar]
  • 52.Rounsaville BJ, Bryant K, Babor T, Kranzler H, Kadden R. Cross system agreement for substance use disorders: DSM-III-R, DSM-IV and ICD-10. Addiction. 1993;88(3):337–48. Epub 1993/03/01. doi: 10.1111/j.1360-0443.1993.tb00821.x . [DOI] [PubMed] [Google Scholar]
  • 53.Hasin D. Classification of alcohol use disorders. Alcohol Res Health. 2003;27(1):5–17. Epub 2004/08/11. ; PubMed Central PMCID: PMC6676702. [PMC free article] [PubMed] [Google Scholar]
  • 54.Fujiwara E, Brand M, Borsutzky S, Steingass HP, Markowitsch HJ. Cognitive performance of detoxified alcoholic Korsakoff syndrome patients remains stable over two years. J Clin Exp Neuropsychol. 2008;30(5):576–87. Epub 2007/09/14. doi: 10.1080/13803390701557271 . [DOI] [PubMed] [Google Scholar]
  • 55.Kim NY, Wittenberg E, Nam CS. Behavioral and Neural Correlates of Executive Function: Interplay between Inhibition and Updating Processes. Frontiers in neuroscience. 2017;11:378-. doi: 10.3389/fnins.2017.00378 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Rottschy C, Langner R, Dogan I, Reetz K, Laird AR, Schulz JB, et al. Modelling neural correlates of working memory: a coordinate-based meta-analysis. Neuroimage. 2012;60(1):830–46. doi: 10.1016/j.neuroimage.2011.11.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Wagner S, Sebastian A, Lieb K, Tüscher O, Tadić A. A coordinate-based ALE functional MRI meta-analysis of brain activation during verbal fluency tasks in healthy control subjects. BMC neuroscience. 2014;15(1):1–13. doi: 10.1186/1471-2202-15-19 PubMed Central PMCID: PMC3903437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Emch M, von Bastian CC, Koch K. Neural correlates of verbal working memory: an fMRI meta-analysis. Frontiers in human neuroscience. 2019;13:180. doi: 10.3389/fnhum.2019.00180 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Andreasen NC O ’Leary DS, Arndt S, Cizadlo T, Hurtig R, Rezai K, et al. Short-term and long-term verbal memory: a positron emission tomography study. Proc Natl Acad Sci U S A. 1995;92(11):5111–5. doi: 10.1073/pnas.92.11.5111 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Diamond A. Close interrelation of motor development and cognitive development and of the cerebellum and prefrontal cortex. Child development. 2000;71(1):44–56. doi: 10.1111/1467-8624.00117 [DOI] [PubMed] [Google Scholar]
  • 61.Dijkstra N, Bosch SE, van Gerven MAJ. Shared Neural Mechanisms of Visual Perception and Imagery. Trends in Cognitive Sciences. 2019;23(5):423–34. doi: 10.1016/j.tics.2019.02.004 [DOI] [PubMed] [Google Scholar]
  • 62.Schurgin MW. Visual memory, the long and the short of it: A review of visual working memory and long-term memory. Attention, Perception, & Psychophysics. 2018;80(5):1035–56. doi: 10.3758/s13414-018-1522-y [DOI] [PubMed] [Google Scholar]
  • 63.Indefrey P. The spatial and temporal signatures of word production components: a critical update. Frontiers in psychology. 2011;2:255. doi: 10.3389/fpsyg.2011.00255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Fusar-Poli P, Placentino A, Carletti F, Landi P, Allen P, Surguladze S, et al. Functional atlas of emotional faces processing: A voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. Journal of Psychiatry & Neuroscience. 2009;34(6):418–32. PubMed Central PMCID: PMC2783433. [PMC free article] [PubMed] [Google Scholar]
  • 65.Li L, Yu H, Liu Y, Meng Y-j, Li X-j, Zhang C, et al. Lower regional grey matter in alcohol use disorders: evidence from a voxel-based meta-analysis. BMC Psychiatry. 2021;21(1):247. doi: 10.1186/s12888-021-03244-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Klaming R, Harlé KM, Infante MA, Bomyea J, Kim C, Spadoni AD. Shared gray matter reductions across alcohol use disorder and posttraumatic stress disorder in the anterior cingulate cortex: A dual meta-analysis. Neurobiol Stress. 2019;10:100132. doi: 10.1016/j.ynstr.2018.09.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Yang X, Tian F, Zhang H, Zeng J, Chen T, Wang S, et al. Cortical and subcortical gray matter shrinkage in alcohol-use disorders: a voxel-based meta-analysis. Neurosci Biobehav Rev. 2016;66:92–103. doi: 10.1016/j.neubiorev.2016.03.034 [DOI] [PubMed] [Google Scholar]
  • 68.Xiao P, Dai Z, Zhong J, Zhu Y, Shi H, Pan P. Regional gray matter deficits in alcohol dependence: A meta-analysis of voxel-based morphometry studies. Drug Alcohol Depend. 2015;153:22–8. doi: 10.1016/j.drugalcdep.2015.05.030 [DOI] [PubMed] [Google Scholar]
  • 69.Zou X, Durazzo TC, Meyerhoff DJ. Regional Brain Volume Changes in Alcohol-Dependent Individuals During Short-Term and Long-Term Abstinence. Alcohol Clin Exp Res. 2018;42(6):1062–72. Epub 2018/04/20. doi: 10.1111/acer.13757 ; PubMed Central PMCID: PMC5984169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Oscar-Berman M, Marinkovic K. Alcoholism and the brain: an overview. Alcohol Res Health. 2003;27(2):125. PubMed Central PMCID: PMC6668884. [PMC free article] [PubMed] [Google Scholar]
  • 71.Benzerouk F, Gierski F, Gorwood P, Ramoz N, Stefaniak N, Hübsch B, et al. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and its implication in executive functions in adult offspring of alcohol-dependent probands. Alcohol. 2013;47(4):271–4. doi: 10.1016/j.alcohol.2013.03.001 [DOI] [PubMed] [Google Scholar]
  • 72.Kamarajan C, Porjesz B, Jones KA, Choi K, Chorlian DB, Padmanabhapillai A, et al. The role of brain oscillations as functional correlates of cognitive systems: a study of frontal inhibitory control in alcoholism. International Journal of Psychophysiology. 2004;51(2):155–80. doi: 10.1016/j.ijpsycho.2003.09.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Ellis RJ, Oscar-Berman M. Alcoholism, aging, and functional cerebral asymmetries. Psychol Bull. 1989;106(1):128–47. Epub 1989/07/01. doi: 10.1037/0033-2909.106.1.128 . [DOI] [PubMed] [Google Scholar]
  • 74.Oscar-Berman M, Noronha A, Eckardt M, Warren K. Review of NIAAA’s neuroscience and behavioral research portfolio. Bethesda, MD: the Institute. 2000:437–72. [Google Scholar]
  • 75.Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E MZ, editor. JBI Manual for Evidence Synthesis: JBI; 2020. [Google Scholar]
  • 76.Keaney F, Gossop M, Dimech A, Guerrini I, Butterworth M, Al-Hassani H, et al. Physical health problems among patients seeking treatment for substance use disorders: A comparison of drug dependent and alcohol dependent patients. J Subst Use. 2011;16(1):27–37. doi: 10.3109/14659890903580474 [DOI] [Google Scholar]
  • 77.Klimkiewicz A, Klimkiewicz J, Jakubczyk A, Kieres-Salomoński I, Wojnar M. Comorbidity of alcohol dependence with other psychiatric disorders. Part I. Epidemiology of dual diagnosis. Psychiatr Pol. 2015;49(2):265–75. doi: 10.12740/PP/25704 [DOI] [PubMed] [Google Scholar]
  • 78.Nigg JT, Jester JM, Stavro GM, Ip KI, Puttler LI, Zucker RA. Specificity of executive functioning and processing speed problems in common psychopathology. Neuropsychology. 2017;31(4):448. doi: 10.1037/neu0000343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Gudayol-Ferré E, Duarte-Rosas P, Peró-Cebollero M, Guàrdia-Olmos J. The effect of second-generation antidepressant treatment on the attention and mental processing speed of patients with major depressive disorder: A meta-analysis study with structural equation models. Psychiatry Res. 2022;314:114662. doi: 10.1016/j.psychres.2022.114662 [DOI] [PubMed] [Google Scholar]
  • 80.Collie A. Cognition in liver disease. Liver International. 2005;25(1):1–8. doi: 10.1111/j.1478-3231.2005.01012.x [DOI] [PubMed] [Google Scholar]
  • 81.Saunders JB, Degenhardt L, Reed GM, Poznyak V. Alcohol use disorders in ICD‐11: Past, present, and future. Alcohol Clin Exp Res. 2019;43(8):1617–31. doi: 10.1111/acer.14128 [DOI] [PubMed] [Google Scholar]
  • 82.Koob GF. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. Behavioral neurobiology of alcohol addiction. 2013:3–30. doi: 10.1007/7854_2011_129 PubMed Central PMCID: PMC3448980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.López-Caneda E, Rodríguez Holguín S, Cadaveira F, Corral M, Doallo S. Impact of Alcohol Use on Inhibitory Control (and Vice Versa) During Adolescence and Young Adulthood: A Review. Alcohol Alcohol. 2013;49(2):173–81. doi: 10.1093/alcalc/agt168 [DOI] [PubMed] [Google Scholar]
  • 84.Jansari AS, Devlin A, Agnew R, Akesson K, Murphy L, Leadbetter T. Ecological assessment of executive functions: a new virtual reality paradigm. Brain Impair. 2014;15(2):71–87. doi: 10.1017/BrImp.2014.14 [DOI] [Google Scholar]
  • 85.Finn PR, Justus A, Mazas C, Steinmetz JE. Working memory, executive processes and the effects of alcohol on Go/No-Go learning: testing a model of behavioral regulation and impulsivity. Psychopharmacology. 1999;146:465–72. doi: 10.1007/pl00005492 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Valerio Manippa

20 Sep 2023

PONE-D-23-18208Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an Alcohol Use Disorder: Systematic review of longitudinal studiesPLOS ONE

Dear Dr. Powell,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 04 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Valerio Manippa

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for this important and well conducted review. The most important aspect is that cognitive functions can be restored in people who are willing and ready to achieve abstinence from alcohol. Some recommendations for clinicians to include these information in motivational interviews for patients making sure they avoid any judgement and stigmatising language and a plain language version for alcohol service users to be aware that some of their difficulties can be overcome and full functionality recuperated would increase the already good contribution of this paper.

I wonder whether an additional paragraph with implications for research and for practices could be added to this paper.

Reviewer #2: This review aim to synthetis changes in neuropsychological performances in patients with AUD. It notably shows that approximately the majority of the patients who were initially impaired at baseline no longer exhibited any deficit at follow-up. By doing so, the authors address a central matter in the field of AUD, as identifying the recovery of cognitive deficits

While I recognize the importance of such explorations, and acknowledge some of the strengths of this review, and notably its willingness to control more confounding factors compared to previous similar work, I also have a few comments and remarks that I believe may help to improve the paper before it can be considered for publication. These remarks especially concern methodological aspects that may render some results potentially misleading in their current form.

Major comments

First of all, the authors should highlight the originality of this review and the added value, compared to previous reviews in the introduction section (notably, stravo et al, 2012 Addic Biol).

Secondly, the exact time of recovery had not been systematically reported in the results section of the manuscript or at least in the discussion. I know that the time points of the follow up assesment are indicated in tables and figures, but it would be useful to readers to be aware of the Many discrepancies between the studies regarding the exact time of recovery, (ex: range of recovery ?). It would be interesting at least to discuss this aspect, and to provide hypothesis to improve future studies in this field.

Finally, the authors have correctly noticed that many cofounders have been included in the analysis of cognitive impairement. However important limitations can be added to the exclusion criteria of the studies notably the use of psychotropic medications or the presence of liver disease such as cirrhosis , that may impaired cognitive assesment of patients with AUD. Please add this subject in the discussion section.

Minor comments

Can you explain why studies such as Mulhauser et al., 2018, Luqiens 2019, Angerville et al. 2023...were not included in the review ?

page 4, line 77 " A comparator was required, in the form of adults aged 18-24 without AUD"

Why the comparator (control group was aged 18-24 while the inclusion criteria was AUD patient aged 18-54 ?

can you explain why the comparator (control group) should be used at least at baseline ? it would be interesting regarding the aim of the review to include studies using compartors at follow up comparaison also?

why a metaanalysis could not be performed ?

Reviewer #3: This work addresses the question of recovery of neuropsychological function following abstinence from AUD through a systematic review of longitudinal studies.

The systematic review was conducted from 1999 with a review protocol previously published (Powel et al., 2022).

The analysis is detailed and carefully carried out, but there is a lack of synthesis, which reduces the effectiveness of the message to the reader. This paper should be improved by clarifying and concisely presenting the main findings.

Indeed, the authors refer to a previous study (Powell et al. 2022) to justify the editorial brevity (Introduction, Objectives, Methods). This does not necessarily explain the lack of drafting (see Introduction) and deserves clarification.

Especially, the brief introduction fails to present the context of the research, whether it is the scientific question about recovery of neuropsychological function after abstinence or the methodology used for the systematic review in the context of previous research in this area. Whilst the authors' would like us to refer back to their previous publication, this is not clearly stated in the introduction and requires further clarification of the context. The interest of the subject is not justified.

The objectives are strictly identical to the earlier review by Powell et al. (2022) (6% of the document has been flagged for potential plagiarism by the anti-plagiarism software), however, it is necessary for the authors to provide a better explanation of how they ensured continuity with the previous publication. The aim of this review should explicitly mention that the outcomes presented are a result of the review and not any experimental or observational research. Objectives should be presented in more concrete terms.

The results are then presented by neuropsychological function. To make this section clearer, a presentation of main outcomes would be welcome.

The headings in this section should be adapted.

For the sake of completeness, the authors enumerate findings from the literature in the Discussion section to the detriment of the meaning and message to be conveyed to the reader. In order to draw more precise conclusions, it would be beneficial to complete comparisons with other studies and discuss your findings in relation to the existing literature (for example, see line 466 to 472). Likewise, the overall message to the reader would be clarified by a synthesis of the results and a presentation of the limitations of the literature.

Figures 1 and 2 have no title or legend.

References are not all in the same format. They should be harmonized.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Marica Ferri

Reviewer #2: Yes: Angerville Bernard

Reviewer #3: Yes: Judith André

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jan 2;19(1):e0296043. doi: 10.1371/journal.pone.0296043.r002

Author response to Decision Letter 0


4 Nov 2023

Dear Professor Emily Chenette,

Thank you for giving us the opportunity to submit a revised draft of our manuscript titled ‘Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an Alcohol Use Disorder: Systematic review of longitudinal studies’ to PLOS ONE (Manuscript ID: PONE-D-23-18208). We appreciate the time and effort that you and the reviewers have dedicated to providing valuable feedback on our manuscript. We are grateful for the insightful comments on our paper. We have been able to incorporate changes that reflect most of the suggestions provided.

We look forward to hearing from you in due time regarding our submission and to respond to any further questions and comments you may have.

Sincerely,

Anna Powell

Here is a point-by-point response to the reviewers’ comments and concerns.

Reviewer 1:

1. Thank you for this important and well conducted review.

Response: We thank Reviewer 1 for the positive comment.

2. The most important aspect is that cognitive functions can be restored in people who are willing and ready to achieve abstinence from alcohol. Some recommendations for clinicians to include these information in motivational interviews for patients making sure they avoid any judgement and stigmatising language and a plain language version for alcohol service users to be aware that some of their difficulties can be overcome and full functionality recuperated would increase the already good contribution of this paper. I wonder whether an additional paragraph with implications for research and for practices could be added to this paper.

Response: Reviewer 1 raises a good point. We had originally given some information on future research in the conclusion, however, agree that an earlier section with more detail on both this and implications for practice, would be better. We have therefore added this (with the brilliant suggestion by Reviewer 1 of motivational interviewing techniques to provide this information to patients), and have adapted the conclusion accordingly. Location(s): lines 702-736, 746-759

Reviewer 2:

1. This review aims to synthesise changes in neuropsychological performances in patients with AUD. It notably shows that approximately the majority of the patients who were initially impaired at baseline no longer exhibited any deficit at follow-up. By doing so, the authors address a central matter in the field of AUD, as identifying the recovery of cognitive deficits. While I recognize the importance of such explorations, and acknowledge some of the strengths of this review, and notably its willingness to control more confounding factors compared to previous similar work, I also have a few comments and remarks that I believe may help to improve the paper before it can be considered for publication. These remarks especially concern methodological aspects that may render some results potentially misleading in their current form.

Response: We thank Reviewer 2 for their positive feedback, and for their useful critique.

1. First of all, the authors should highlight the originality of this review and the added value, compared to previous reviews in the introduction section (notably, stravo et al, 2012 Addic Biol).

Response: We agree, and so in response to comments by Reviewer 2 and 3, we have rewritten the introduction to better justify the review, particularly by highlighting the importance of reviewing longitudinal work and grouping tasks under multiple function domains and sub-domains. We have also directed readers to the published protocol for more information on the justification of the review - due to the length of the paper, we are hesitant to extend it further by lengthening the introduction more, though if Reviewer 2 feels strongly about this we are happy to further revise the introduction. For clarity, we have also highlighted in the methods section that we grouped tasks across multiple domains. Location(s): lines 52-75, 74-75, 117-119

2. Secondly, the exact time of recovery had not been systematically reported in the results section of the manuscript or at least in the discussion. I know that the time points of the follow up assesment are indicated in tables and figures, but it would be useful to readers to be aware of the Many discrepancies between the studies regarding the exact time of recovery, (ex: range of recovery ?). It would be interesting at least to discuss this aspect, and to provide hypothesis to improve future studies in this field.

Response: We appreciate this insight by Reviewer 2. We have updated the manuscript to include range of follow-up time for each function in the relevant narrative synthesis sections of the result section. We have also suggested that future research seeks to capture regular follow-up assessments up to and beyond at least a year of abstinence. Location(s): lines 729-730

3. Finally, the authors have correctly noticed that many cofounders have been included in the analysis of cognitive impairement. However important limitations can be added to the exclusion criteria of the studies notably the use of psychotropic medications or the presence of liver disease such as cirrhosis , that may impaired cognitive assesment of patients with AUD. Please add this subject in the discussion section.

Response: Thank you for this comment. We had acknowledged in the Robustness of Synthesis section that the inability to control for confounds such as practice effects, medication, and comorbid health problems, was a limitation of the review. However, in accordance with your comment, we have now highlighted within this that specifically cirrhosis and psychiatric disorders are highly comorbid and impact cognitive function, and that the related treatment (e.g., psychotropic medications) can also impact function, and that these should be excluded where feasible. Location(s): lines 690-696

4. Can you explain why studies such as Mulhauser et al., 2018, Luqiens 2019, Angerville et al. 2023...were not included in the review ?

Response: We appreciate Reviewer 2 for bringing these studies to our attention, as two of them were not returned by our search strategy. One of these two has now been included in the review. Of the three studies:

Mulhauser et al. (2018) and Luquiens et al. (2019) do not meet inclusion criteria for the review, due to their including several patients with a comorbid substance use disorder (cannabis use disorder, and cocaine use disorder) as part of their AUD sample. Our review criteria states that for papers in which participants are reported as consuming other substances as well as alcohol, alcohol must be the primary substance, which is not the case where the disorders are described as comorbid. This could confound the results of the papers, and subsequently the review synthesis, no other papers included report on AUD participants with comorbid substance use disorders. An exception in the criteria (described in the protocol) is the SUD tobacco use disorder, due to its particularly high comorbidity with AUD. This has been made clearer in the review Method section (lines 98-101). Additionally, Luquiens et al., (2019) only recruited patients with a MoCA score of <26, which is a screening indicator for ARBI, and would have excluded this study alone.

Angerville et al. (2023) had not previously been returned as part of our search strategy, and as this paper excluded participants with a history or current use of other substances, and meets the rest of the inclusion criteria, it has been added to the review. We thank Reviewer 2 for this addition. Furthermore, in the process of adding this paper, we realised there had previously been an issue with some incorrect value recording in the PRISMA flow-chart, which has now been fixed.

5. page 4, line 77 " A comparator was required, in the form of adults aged 18-24 without AUD". Why the comparator (control group was aged 18-24 while the inclusion criteria was AUD patient aged 18-54 ?

We thank Reviewer 2 for bringing this to our attention, this was a typo, and has been corrected, both sentences now state “adults aged 18-64”. Location(s): line 94

6. can you explain why the comparator (control group) should be used at least at baseline ? it would be interesting regarding the aim of the review to include studies using compartors at follow up comparaison also?

Response: Seven of the studies included in this review did include control group comparison at one or more follow-up assessments, Table 1 column ‘Comparator’ gives more clarification on this, and it is also described in the first paragraph of the results. Of the eleven studies which compared cognitive function in recovery to controls, only four did so once. Location(s): Table 1, lines 125-128

7. why a metaanalysis could not be performed?

Response: Due to the breadth of cognitive functions assessed, there was significant heterogeneity across the studies included in this review, which meant that meta-analysis was not suitable. This is touched on briefly in the Method section (line 114), and was anticipated when we designed the review protocol as a planned narrative synthesis (see Powell et al. (2022)).

As we knew we would not be able to conduct meta-analysis, we ensured that our narrative synthesis strategy was well-planned in accordance with Popay et al. (2006) and the University of York’s Centre for Reviews and Dissemination (2009), using multiple grouping of tasks (Schulte et al., 2014) and the well-known Lezak et al. (2012) book Neuropsychological Assessment as guidance for the grouping process, and with the matrix to provide a visual basis for the written synthesis. As our protocol was published, we also ensured that the narrative synthesis methods received peer review and approval prior to beginning this process.

Reviewer 3:

1. This work addresses the question of recovery of neuropsychological function following abstinence from AUD through a systematic review of longitudinal studies. The systematic review was conducted from 1999 with a review protocol previously published (Powel et al., 2022). The analysis is detailed and carefully carried out, but there is a lack of synthesis, which reduces the effectiveness of the message to the reader. This paper should be improved by clarifying and concisely presenting the main findings.

Response: We thank Reviewer 3 for their time providing thoughtful feedback on our paper, and for their positive comment on our attention to detail. In response to another of Reviewer 3’s comments, we have clarified the main findings in the first paragraph of the results, and added a more detailed summary of the synthesis to the discussion, to improve the overall synthesis of the review. Location(s): lines 131-134, 547-570

2. Indeed, the authors refer to a previous study (Powell et al. 2022) to justify the editorial brevity (Introduction, Objectives, Methods). This does not necessarily explain the lack of drafting (see Introduction) and deserves clarification.

Response: We agree, and so in response to comments by Reviewer 2 and 3, we have rewritten the introduction to better justify the review. We have also directed readers to the published protocol for more information on the justification of the review - due to the length of the paper, we are hesitant to extend it further by lengthening the introduction more, though if Reviewer 3 feels strongly about this we are happy to further revise the introduction. Location: lines 55-75,

Regarding review methods, there is a sentence directing readers to the published protocol in the Methods section if they wish to read a more detailed description. Location: lines 81-83

3. Especially, the brief introduction fails to present the context of the research, whether it is the scientific question about recovery of neuropsychological function after abstinence or the methodology used for the systematic review in the context of previous research in this area. Whilst the authors' would like us to refer back to their previous publication, this is not clearly stated in the introduction and requires further clarification of the context. The interest of the subject is not justified.

Response: Please see response to Reviewer 3 comment 2.

4. The objectives are strictly identical to the earlier review by Powell et al. (2022) (6% of the document has been flagged for potential plagiarism by the anti-plagiarism software), however, it is necessary for the authors to provide a better explanation of how they ensured continuity with the previous publication.

Response: The objectives for this review are consistent with those of the protocol because it was adhered to consistently. We agree that this may not have been clear, and have made a note in the methods section to this effect. Location: line 81

5. The aim of this review should explicitly mention that the outcomes presented are a result of the review and not any experimental or observational research. Objectives should be presented in more concrete terms.

Response: We have added a statement to this effect to the Objective(s) section, however as our objectives follow those of the published protocol, we do not feel it would be appropriate to deviate from this. Location: line 77

6. The results are then presented by neuropsychological function. To make this section clearer, a presentation of main outcomes would be welcome. The headings in this section should be adapted.

Response: We agree that there was a lack of clarity regarding main findings in this section, and have added to the first paragraph of the results highlighting these (line 131-134). Headings within the results relate to the function groupings, which were informed by the well-known Lezak et al. (2012) book Neuropsychological Assessment, which we feel is the best way to present this information. It is also how we proposed we would group, describe, and discuss data in the synthesis, in our published proposal, so do not wish to deviate from this if we can avoid it.

7. For the sake of completeness, the authors enumerate findings from the literature in the Discussion section to the detriment of the meaning and message to be conveyed to the reader. In order to draw more precise conclusions, it would be beneficial to complete comparisons with other studies and discuss your findings in relation to the existing literature (for example, see line 466 to 472).

Response: We thank Reviewer 3 for this comment, we agree and have added a more in-depth exploration of the results, specifically in comparison to Schulte et al. (2014) whose review methodology was most like ours. We have also highlighted that the differential recovery of executive functions supports literature suggesting that these are separable abilities. We hope the discussion is now acceptable to Reviewer 3. Location: lines 573-593

8. Likewise, the overall message to the reader would be clarified by a synthesis of the results and a presentation of the limitations of the literature.

Response: As mentioned, we have made several changes to improve the synthesis of the review, including clarifying the main findings in the results section (lines 131-134), adding a more detailed summary of the synthesis to the discussion (lines 547-570), and adding a more in-depth view of how this work sits in relation to previous literature (lines 573-593). In response to a comment by Reviewer 1, we have also added a section on Future Research and Implications for Practice (lines 702-736), which we hope will also improve the overall message to the reader. Limitations of the literature are addressed in the Robustness of Synthesis section (lines 640-675).

9. Figures 1 and 2 have no title or legend.

Response: Thank you for this comment. We have adhered to PLOS ONE guidelines, in which figure titles are inserted immediately in-text after the first paragraph in which the figure is cited, but figure files are uploaded separately. Therefore, the figure files do not contain the titles, but the manuscript itself does.

10. References are not all in the same format. They should be harmonized.

Our thanks to Reviewer 3 for bringing this to our attention, upon checking, we realised that there had been an issue with the DOI format being different between references, which we have rectified.

Angerville, B., Ritz, L., Pitel, A.-L., Beaunieux, H., Houchi, H., Martinetti, M. P., . . . Dervaux, A. (2023). Early Improvement of Neuropsychological Impairments During Detoxification in Patients with Alcohol Use Disorder. Alcohol and Alcoholism, 58(1), 46-53. https://doi.org/10.1093/alcalc/agac048

Centre for Reviews and Dissemination. (2009). Systematic reviews: CRD's guidance for undertaking reviews in healthcare. York: University of York NHS Centre for Reviews & Dissemination.

Lezak, M. D., Howieson, D. B., Bigler, E. D., & Tranel, D. (2012). Neuropsychological assessment, 5th ed. Oxford University Press.

Luquiens, A., Rolland, B., Pelletier, S., Alarcon, R., Donnadieu-Rigole, H., Benyamina, A., . . . Perney, P. (2019). Role of patient sex in early recovery from alcohol-related cognitive impairment: women penalized. Journal of Clinical Medicine, 8(6), 790. https://doi.org/10.3390/jcm8060790

Mulhauser, K., Weinstock, J., Ruppert, P., & Benware, J. (2018). Changes in neuropsychological status during the initial phase of abstinence in alcohol use disorder: neurocognitive impairment and implications for clinical care. Substance Use & Misuse, 53(6), 881-890. https://doi.org/10.1080/10826084.2017.1408328

Popay, J., Roberts, H., Sowden, A., Petticrew, M., Arai, L., Rodgers, M., . . . Duffy, S. (2006). Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme Version, 1, b92. https://doi.org/10.13140/2.1.1018.4643

Powell, A., Sumnall, H., Smith, J., Kuiper, R., & Montgomery, C. (2022). Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: Protocol for a systematic review of longitudinal studies. PLOS ONE, 17(9), e0274752. https://doi.org/10.1371/journal.pone.0274752

Schulte, M. H. J., Cousijn, J., den Uyl, T. E., Goudriaan, A. E., van den Brink, W., Veltman, D. J., . . . Wiers, R. W. (2014). Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment. Clinical Psychology Review, 34(7), 531-550. https://doi.org/10.1016/j.cpr.2014.08.002

Attachment

Submitted filename: ResponseToReviewers.docx

Decision Letter 1

Valerio Manippa

5 Dec 2023

Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an Alcohol Use Disorder: Systematic review of longitudinal studies

PONE-D-23-18208R1

Dear Dr. Powell,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Valerio Manippa

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Bernard Angerville

**********

Acceptance letter

Valerio Manippa

21 Dec 2023

PONE-D-23-18208R1

PLOS ONE

Dear Dr. Powell,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Valerio Manippa

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. PRISMA 2020 abstracts checklist.

    (PDF)

    S2 Table. PRISMA 2020 checklist.

    (PDF)

    S3 Table. Systematic search strategies for APA PsycInfo, EBSCO MEDLINE, CINAHL, and Web of Science.

    (PDF)

    S4 Table. Papers excluded at the full-text screening stage, with reason for exclusion.

    (PDF)

    Attachment

    Submitted filename: ResponseToReviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES